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Chapter 1 
 
 
General introduction 
 
Structure, distribution and function of the epithelial Na+ channel (ENaC) 
 
ENaC is a heteromeric ion channel, composed of three homologous subunits: α-, β- and 
γENaC. Each subunit consists of short (∼ 50−100 amino acids) intracellular amino- and 
carboxyl termini and two hydrophobic transmembrane domains (M1 and M2) connected by a 
large (∼ 500 amino acids) hydrophilic extracellular loop (Fig. 1; (37;38;71;148)). The C 
terminus contains a highly conserved PPPXYXXL sequence (PY motif), which is important 
for endocytosis and degradation of ENaC (50). 
 
 
 
Fig. 1: Structure of ENaC. Three homologous subunits form the ion channel: 2 α-, 1 β- and 
1 γENaC (66), but other combinations may exist, too (202). 
 
 
Expression and assembly of probably 2 α-, 1 β- and 1 γENaC are necessary to get a full 
functional channel with a few remarkable features (74;81): 
i) non-voltage gated and non-inactivating channel with a high selectivity for Na+ 
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ii) low single channel conductance (∼ 5 pS)  
iii) long closing and opening times 
iv) blocked by the diuretic amiloride at submicromolar concentrations 
 
As a member of the ENaC/DEG superfamily (3;17;103), ENaC plays a key role in Na+ 
transport. Localized in the apical membranes of absorbing epithelia, including kidney, 
airways, distal colon, sweat and salivary ducts (38;66;74), ENaC is responsible for 
electrogenic uptake of Na+ into the cells. At the basolateral membranes, the Na+/K+ ATPase 
is pumping Na+ out of the cells (73). 
 
The regulation of Na+ transport by ENaC is crucial to a variety of physiological functions 
(172): 
i) normal blood pressure 
ii) control of urinary Na+ reabsorption 
iii) maintenance of extracellular fluid volume homeostasis 
iv) regulation of volume and composition of airway surface liquids 
v) mucociliary clearance in airway epithelia 
Changes in expression or activity of ENaC lead to defects in the regulation of Na+ transport 
and cause several human diseases, including Liddle's syndrom (an inherited form of salt-
sensitive hypertension), pseudohypoaldosteronism type I (an inherited form of severe salt-
wasting and hypotension) and cystic fibrosis (28;187). 
 
Regulation of ENaC 
 
Before ENaC subunits were cloned from rat distal colon 1993 (37;130), the knowledge about 
the regulation of ENaC was limited, so that a non-regulated ENaC was taken into account. 
Today, we know a wide variety of hormonal and non-hormonal mechanisms to regulate 
ENaC and to fine-tune Na+ absorption. 
 
Hormonal regulation of ENaC 
 
Several hormones, including aldosterone, insulin and vasopressin, are involved in Na+ 
transport via ENaC. The hormones influence surface expression and/or activity of the Na+ 
channel by stimulating different signalling cascades. 
 
Activation of ENaC via aldosterone-regulated SGK1 
 
Aldosterone (Aldo) is the most important hormonal regulator of renal Na+ absorption. Its 
binding to the mineralocorticoid receptor (6) stimulates transcription of the serum- and 
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glucocorticoid-dependent kinase isoform 1 (SGK1) and other genes (6;29;58;208;222;223). 
After activation of SGK1 by a phosphatidylinositol 3-kinase (PI3K)-dependent pathway (see 
below), SGK1 phosphorylates the ubiquitin ligase Nedd4-2 (50;204). Usually, non-
phosphorylated Nedd4-2 binds to ENaC and tags it with ubiquitin, targeting it for 
internalization and degradation (50;156). But when it is phosphorylated, Nedd4-2 shows 
reduced affinity for ENaC because phosphorylation induces the binding of an inhibitory 14-3-
3 dimer to Nedd4-2 (Fig. 2; (19;93)). As a result, ENaC surface expression increases. In its 
phosphorylated form, Nedd4-2 ubiquitinates SGK1, leading to degradation of the kinase 
(241). This negative feedback mechanism restricts the influence of the SGK1 pathway to 
ENaC. 
 
Insulin-dependent regulation of ENaC 
 
It is well known that insulin (Ins) increases renal Na+ reabsorption, and two models exist, 
which describe the corresponding intracellular signalling. 
Both pathways have a common starting point: 
The binding of insulin to its receptor on the basolateral membrane stimulates phosphorylation 
of the insulin receptor substrate 1 (IRS1), which results in activation of PI3K (173). In the first 
model the activation of PI3K is associated with its translocation to the plasma membrane. 
Here PI3K catalyzes formation of phosphatidylinositol 3,4,5-trisphosphate (PIP3) from 
phosphatidylinositol 4,5-bisphosphate (PIP2) in the inner leaflet of the plasma membrane 
(24). Then, PIP3 diffuses along the lateral membrane, crossing the thight junction and 
entering the apical membrane. This leads to a changed lipid composition, supporting the 
insertion of ENaC into the apical membrane (25). It is assumed that PI3K and ENaC are co-
localized along the lateral membrane from where it moves to the apical side (24). In the 
second pathway model PI3K forms PIP3, leading to activation of phosphatidylinositol-
dependent protein kinases (PDK; (39)). PDK1 phosphorylates SGK1, which enables SGK1 to 
phosphorylate the ubiquitin ligase Nedd4-2 (Fig. 2; (50;204)). Phosphorylation of Nedd4-2 
prevents binding to ENaC and subsequent endocytosis. 
 
Regulation of ENaC by vasopressin 
 
In case of hypovolemia or hypotension, vasopressin (Vaso) is secreted by the hypothalamus 
to enhance Na+ transport in renal collecting duct cells (59). The hormon binds to V2 
receptors at the basolateral membrane and activates the adenylate cyclase (AC), leading to 
an increase in intracellular cAMP. High cAMP levels stimulate protein kinase A (PKA). 
Through phosphorylation of the ubiquitin ligase Nedd4-2, PKA inhibits endocytosis and 
degradation of ENaC (Fig. 2; (203)). The effect of vasopressin is synergistic with that of 
aldosterone. 
Introduction 4
 
ENaC inhibition by epidermal growth factor 
 
The epidermal growth factor receptor (EGFR)-signalling pathway in renal collecting duct cells 
is an example for negative regulation of Na+ absorption by aldosterone (75;115). Aldosterone 
upregulates EGFR (114;115) and Ras (146;207). Activation of this pathway antagonizes its 
own positive action on ENaC (77). Binding of the epidermal growth factor (EGF) to EGFR 
activates via active GTP-complexed Ras, a MAPK1/2 cascade that results in ERK-mediated 
phosphorylation of ENaC (196). This facilitates the interaction between the Na+ channel and 
ubiquitin ligase Nedd4-2 (197), leading to internalization and subsequent degradation of 
ENaC (Fig. 2; (50;156)). 
 
Small GTPases activate ENaC 
 
K-Ras and RhoA are GTP-dependent, small G proteins, which increase ENaC activity 
through distinct and independent signalling cascades (175;205). Aldosterone induces 
expression and activation of K-Ras (82;146;207). The active GTP-bound form of K-Ras 
activates PI3K, which catalyzes formation of PIP3 (206). Subsequent interaction between 
PIP3 and the C terminus of γENaC results in enhanced channel open probability and activity 
of ENaC (177). The RhoA signalling pathway is less understood but it is known that GTP-
complexed RhoA interacts with Rho kinase to activate phosphatidylinositol 4-phosphate 5-
kinase (PI(4)5K; (171;228;233)). Production of PIP2 augments ENaC membrane surface 
expression. Because of the importance of RhoA for cytoskeletal rearrangement and vesicle 
trafficking (185;214) and the role of PIP2 in the exocytotic process (5;100;227), it is assumed 
that RhoA enhances surface expression by promoting trafficking of ENaC to the plasma 
membrane (176). 
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Fig. 2: Hormonal regulation of ENaC. Not all of the described signalling pathways are 
shown here. Small circled Pi, inorganic phosphate. See text for explanations and 
abbreviations. Modified from ref. 20. 
 
 
Non-hormonal regulation of ENaC 
 
Apart from hormonal regulation of the epithelial Na+ channel as outlined in the previous 
paragraphs, also non-hormonal mechanisms for Na+ channel regulation have been 
described. These include phosphorylation not related to hormonal stimulation, interaction 
with phospholipids and in addition, regulation by proteases and other ion channels, which 
interact with ENaC. 
 
Activation of ENaC by proteolysis 
 
Proteases-dependent cleavage of α- and γENaC leads to release of two inhibitory peptides, 
resulting in enhanced channel open probability (Po). The serine endoprotease furin cleaves 
the α subunit at two sites and the γ subunit at a single site within the extracellular loop (92). 
The dual cleavage of αENaC removes a 26 amino acids (aa) inhibitory peptide (41). For the 
excision of a second inhibitory peptide (43 aa), a double cleavage in γENaC must occur. The 
serine protease prostasin cleaves this subunit at a site distal to the furin cleavage site (35).  
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Regulation of ENaC by PIP2 
 
The anionic phospholipid phosphatidylinositol 4,5-bisphosphate (PIP2) is localized in the 
inner leaflet of the plasma membrane and consists of a lipophilic tail, anchoring PIP2 in the 
membrane and a hydrophilic, negatively charged head group, which extends into the 
cytoplasm and allows interaction with cytosolic proteins. Some of its purposes are the 
activation of enzymes and the regulation of transporters and ion channels (83). The epithelial 
Na+ channel is one of them (137;235) and chapter 2 (119) describes one possible way for 
ENaC regulation via PIP2. As mentioned above, PIP2 is involved in enhancing surface 
expression of ENaC via distinct signalling cascades. However, these known pathways do not 
require direct binding of PIP2 to the channel.  
 
It was demonstrated that there are PIP2 binding sites in the N termini of β- and γENaC and 
direct interaction between PIP2 and ENaC has been detected, influencing the open 
probability of the channel (137;235). Furthermore, it is known that stimulation of purinergic 
receptors inhibits epithelial Na+ channels (47;127;190). For that a phospholipase C (PLC)-
dependent mechanism is proposed (124;136). Chapter 2 (119) presents a regulatory 
pathway taking the following into account: Stimulation of the purinergic P2Y2 receptors by 
extracellular ATP activates PLC, leading to hydrolysis of PIP2. A drop in PIP2 levels causes a 
decrease in ENaC open probability. 
 
Protein kinase CK2 regulates ENaC 
 
CK2 is a constitutively active Ser/Thr protein kinase that is ubiquitously expressed in 
eukaryots. The enzyme is composed of two catalytic α- and two regulatory β subunits, 
forming a heterotetramer that targets more than 300 proteins (131;151). With that, CK2 is 
involved in numerous cellular processes such as regulation of protein expression, cell 
proliferation and development (23). Furthermore, it fulfils also a role in regulation of ion 
channels like CFTR and ENaC. In the C termini of β- and γENaC there are binding- and 
phosphorylation sites for CK2 (198). The phosphorylation of these sites by CK2 influences 
both surface expression and open probability of ENaC, although not to the same extent. 
CK2-dependent regulation of ENaC will be subject of chapter 5 (8). 
 
CFTR-mediated inhibition of ENaC 
 
The cystic fibrosis transmembrane conductance regulator (CFTR) is a member of the ATP 
binding cassette (ABC) transporter superfamily. CFTR functions as a Cl− channel in the 
apical membrane of epithelial tissues, including kidney, airways, intestine and sweat ducts 
and participates in ion and water transport across the epithelium. The cAMP-dependent 
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phosphorylation via PKA and the binding and hydrolysis of ATP regulate the activity of this 
Cl− channel (70). CFTR, in turn, also controls numerous other proteins, including the 
epithelial Na+ channel (210). Chapter 3 (9) will deal with this, too.  
 
Cystic fibrosis (CF) is a lethal, autosomal recessive disease of the Caucasian population and 
is caused by mutations in the CFTR gene (26). One mutation alone, F508del-CFTR, is found 
in approximately 90% of CF patients (27). Typical for CF is a deficient Cl− secretion and an 
enhanced Na+ absorption in airways mediated by ENaC, leading ultimately to respiratory 
failure, the most common cause of death in CF patients (104). The loss of CFTR-dependent 
inhibition of ENaC in CF and the resulting clinical problems of defective mucociliary 
clearance illustrate the biological relevance of the interaction between CFTR and ENaC. That 
is why great efforts are spent on the identification of the underlying mechanism. In chapter 3 
(9) it is demonstrated that Cl− ions as well as the C terminus of βENaC are involved in CFTR-
mediated inhibition of ENaC. 
 
Thesis outline 
 
Regulation of epithelial Na+ channels became very complex. Numerous regulatory pathways 
are known, but for most of them no detailed knowledge exists. This thesis aims in 
deciphering several of these regulatory mechanisms in more detail. The different regulatory 
pathways described here have in common that they are either based on the function of 
CFTR or on Cl− ions moving through CFTR Cl− channels. 
 
The first part (chapter 2 (119)) focuses on the inhibition of epithelial Na+ channels by 
stimulation of purinergic receptors (47;124;127;190). The hypothesis is put forward that the 
negatively charged phospholipid PIP2 directly interacts with positively charged sequences 
within the N termini of β- and γENaC, which influences the open probability of the channel. 
We wonder whether hydrolysis of PIP2, caused by stimulation of purinergic receptors and a 
decline in PIP2 levels, is responsible for the decrease in ENaC activity. We consider also a 
Cl−-dependence of this receptor-mediated inhibition. That could mean, Cl− ions compete 
against PIP2 for the binding to the ENaC subunits. 
 
The second part (chapter 3 (9)) deals with Cl−-dependent inhibition of ENaC. It is known that 
activation of CFTR inhibits ENaC (34;95;98;111;129;138;139;142;210). We were interested 
in the role of Cl− ions in CFTR-mediated ENaC inhibition. Furthermore, we want to know to 
what extent the C termini of ENaC subunits are involved in this mechanism.  
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Considering the importance of CFTR for ENaC regulation, the third part (chapter 4 (155)) 
describes the creation of two new cell lines, in order to have better cell models for CFTR-
related studies. Madin-Darby canine kidney (MDCK) cells were used for that because 
• they are polarized epithelial cells (153;161;200). Hitherto most CFTR studies were carried 
out in non-epithelial/non-polarized cells. However, protein trafficking and membrane 
expression in non-epithelial cells is different to that observed in epithelial cells. 
Investigation of protein trafficking is a major issue in CFTR research, since about 80% of all 
patients with cystic fibrosis demonstrate a trafficking defect of CFTR. Trafficking pathways 
in MDCK cells are well-documented (161). 
• they grow well on permeable supports and form tight junctions. That makes MDCK cells 
very suitable for Ussing chamber experiments (an electrophysiological method to measure 
transepithelial voltages; (158)). 
• MDCK type II cells have no endogenous CFTR. Two types of MDCK cells exist (184). Type 
I are derived from the distal collecting duct and express endogenous CFTR (14). Type II 
are derived from the proximal tubule and have no endogenous CFTR (159). 
These and other cellular properties are the reason why MDCK type II cells were taken to 
generate two new cell lines, stably expressing wt- or F508del-CFTR. 
 
In the fourth part of the thesis (chapter 5 (8)) we investigate the involvement of protein kinase 
CK2 in the regulation of epithelial Na+ channels. CFTR functions not only as a regulator of 
ENaC but also as an anchor for numerous other proteins, e.g. protein kinase CK2. CK2 binds 
to and phosphorylates CFTR (150;216). However, there are also binding- and 
phosphorylation sites for CK2 within the C termini of β- and γENaC (198). This raises the 
question whether proteins, in this case CK2, that bind to CFTR, take also part in the 
regulation of ENaC. 
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Chapter 2 
 
 
Purinergic inhibition of the epithelial Na+ transport via hydrolysis of 
PIP2 
 
Abstract 
 
Stimulation of purinergic receptors inhibits amiloride-sensitive Na+ transport in epithelial 
tissues by an unknown mechanism. Because previous studies excluded the role of 
intracellular Ca2+ or protein kinase C, we examined whether purinergic regulation of Na+ 
absorption occurs via hydrolysis of phospholipid such as phosphatidylinositol-bisphosphates 
(PIP2). Inhibition of amiloride-sensitive short-circuit currents (Isc-Amil) by adenine 5’-
triphosphate (ATP) in native tracheal epithelia and M1 collecting duct cells was suppressed 
by binding of neomycin to PIP2, and recovery from ATP inhibition was abolished by blocking 
phosphatidylinositol 4-kinase or diacylglycerol kinase. Stimulation by ATP depleted PIP2 from 
apical membranes, and PIP2 co-immunoprecipitated the β subunit of ENaC. ENaC was 
inhibited by ATP stimulation of P2Y2 receptors in Xenopus oocytes. Mutations in the PIP2 
binding domain of βENaC but not γENaC reduced ENaC currents without affecting surface 
expression. Collectively, these data supply evidence for a novel and physiologically relevant 
regulation of ENaC in epithelial tissues. Although surface expression is controlled by its C 
terminus, N-terminal binding of βENaC to PIP2 determines channel activity. 
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Introduction 
 
Na+ absorption in kidney, airways, colon, and other epithelial tissues is provided by the 
amiloride-sensitive Na+ channel ENaC. Stimulation of luminal purinergic receptors co-
localized with ENaC in luminal membranes transiently activates Ca2+-dependent Cl– 
secretion and induces long-lasting inhibition of Na+ absorption. This has become an 
important issue for the pharmacotherapy of cystic fibrosis (CF), where increased Na+ 
absorption is found in the airways of CF patients (30;122;181). 
 
We and others reported recently regulation of amiloride-sensitive Na+ absorption (Isc-Amil) in 
native trachea and mouse collecting duct (M1) cells by stimulating purinergic receptors with 
ATP or UTP (47;124;127;190). Inhibition of Na+ absorption during stimulation of purinergic 
P2Y receptors with ATP is independent of an increase in intracellular Ca2+ or activation of 
protein kinase C (124;143;143). It was shown, however, that U73122, an inhibitor of 
phospholipase C (PLC) but not the inactive homologue U73343, suppresses the effects of 
ATP on Na+ absorption in mouse trachea. Thus a PLC-dependent process was suggested 
(124;136). ATP-dependent inhibition via activation of PLC was also shown to mask a stretch 
activation of ENaC, as membrane stretch causes release of ATP (136). Two recent 
publications supply evidence for the regulation of ENaC by anionic phospholipids in A6 cells 
and Xenopus oocytes (137;235). Both β- and γ subunits of ENaC but not αENaC contain 
substantial numbers of positively charged amino acids in their N termini. These putative N-
terminal phosphatidylinositol 4,5-bisphosphate (PIP2) binding domains of ENaC may regulate 
ENaC activity by binding positively charged amino acids to PIP2. This is further supported by 
co-immunoprecipitation data that suggest binding of both ENaC subunits to PIP2 (235). 
Moreover, the data available provide evidence for PIP2 regulation of the channel open 
probability rather than surface expression or ENaC trafficking (137). Another study, however, 
showed regulation of ENaC by phosphatidylinositol 3,4,5-trisphosphate (IP3) and 
phosphatidylinositol 3,4-bisphosphate rather than phosphatidylinositol 4,5-bisphosphate 
(215). These data are supported by studies that identified IP3 as an early mediator of insulin-
stimulated transport in A6 cells (145;182). Thus, the importance of the putative PIP2 binding 
motifs for maintaining ENaC activity, its relation to cellular PIP2 metabolism, and the 
physiological relevance of PIP2-dependent regulation of ENaC remain obscure. Here we 
provide convincing evidence for a physiologically relevant PIP2-dependent regulation of 
ENaC by demonstrating purinergic inhibition of amiloride-sensitive Na+ absorption through 
hydrolysis of PIP2. 
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Material and Methods 
 
Ussing chamber experiments 
 
Mouse tracheas were removed after sacrificing animals by cervical dislocation and were 
opened by a longitudinal cut. Connective tissues were removed. Tissues were put into cold 
buffer of the following composition (mmol/l): NaCl 145, KCI 3.8, D-glucose 5, MgCI2 1, 
HEPES 5, Ca-gluconate 1.3. The tissues were mounted into a modified Ussing chamber with 
a circular aperture of 0.95 mm2. M1 cells are derived from mouse cortical collecting duct and 
have properties of principal cells (kindly provided by C. Korbmacher, Physiologisches Institut, 
Universität Erlangen, Germany). The cells were grown to confluence on permeable supports, 
and inserts were mounted into a perfused Ussing chamber. The luminal and basolateral 
sides of the epithelium were perfused continuously at a rate of 10 ml/min (chamber volume 2 
ml). The bath solution had the following composition (mmol/l): NaCl 145, KH2PO4 0.4, 
K2HPO4 1.6, D-glucose 5, MgCI2 1, HEPES 5, Ca-gluconate 1.3. pH was adjusted to 7.4. 
Bath solutions were heated to 37°C using a water jacket. 
 
Experiments were performed under open-circuit conditions. Values for transepithelial 
voltages (Vte) were referred to the serosal side of the epithelium. Transepithelial resistance 
(Rte) was determined by applying short (1 s) current pulses (∆l=0.5 µA). Voltage deflections 
obtained under conditions without the mucosa present in the chamber were subtracted from 
those obtained in the presence of the tissues. Rte was calculated according to Ohm's law (Rte 
=∆Vte/∆I). The equivalent short-circuit current (Isc) was calculated (Isc=Vte/Rte), and the 
amiloride-sensitive Isc (Isc-Amil) is used to express the amount of equivalent short-circuit current 
that is inhibited by 10 µmol/l amiloride. Tissue preparations were accepted only if the 
transepithelial resistance exceeded that obtained for an empty chamber at least by a factor 
of 3. The transepithelial resistance of filter grown M1 cells was 320 ± 38 Ωcm2 (n=36), while 
that of mouse trachea was 55.6 ± 6.7 Ωcm2 (n=42). Measurements under open-circuit 
conditions are in general more protective and less exhausting for tissue preparations. They 
seem more likely to reflect the in vivo situation because the epithelium in vivo is not short-
circuited. As a result, the obtained Isc are in general quite high and the recordings are usually 
stable for 3−4 h. 
 
cRNAs for ENaC subunits and ENaC PIP2 binding mutants 
 
cDNAs encoding rat αβγENaC (kindly provided by B. Rossier, Pharmacological Institute of 
Lausanne, Switzerland) and the purinergic P2Y2 receptor were linearized in pBluescript or 
pTLN (105) with NotI or Mlul and were in vitro transcribed using T7, T3, or SP6 promotor and 
polymerase (Promega, Madison, WI). For some experiments, cDNAs of αβγENaC subunits 
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were used, which were FLAG-tagged (kindly provided by B. Rossier, University of Lausanne, 
Switzerland, (67)). Isolation and microinjection of oocytes have been described in a previous 
report (141). In brief, after isolation from adult Xenopus laevis female frogs (Xenopus 
express, South Africa), oocytes were dispersed and defolliculated by a 45 min-treatment with 
collagenase (type A, Boehringer, Germany). Subsequently, oocytes were rinsed and kept at 
18°C in ND96-buffer (in mmol/l): NaCl 96, KCI 2, CaCI2 1.8, MgCI2 1, HEPES 5, sodium 
pyruvate 2.5 (pH 7.55), supplemented with theophylline (0.5 mmol/l) and gentamycin (5 
mg/l). Mutations in the N-terminal PIP2 binding domains of β- and γENaC were generated by 
replacing 2 (β2N, γ2N) and 4 (β4N, γ4N) positively charged amino acids by non-polar (N) 
amino acids as shown in Fig. 5A, using PCR techniques (191). 
 
Double electrode voltage clamp 
 
Oocytes were injected with cRNA (1−10 ng) after dissolving in 47 nl double-distilled water 
(Nanoliter Injector WPI, Germany). Water-injected oocytes served as controls. Two to four 
days after injection, oocytes were impaled with two electrodes (Clark instruments), which had 
a resistance of <1 MΩ when filled with 2.7 mol/l KCI. Using two bath electrodes and a virtual-
ground headstage, the voltage drop across Rserial was effectively zero. Membrane currents 
were measured by voltage clamping of the oocytes (Warner oocyte clamp amplifier OC725C) 
in intervals from –90 to +30 mV, in steps of 10 mV, each 1 s. Conductances were calculated 
according to Ohm's law, and amiloride-sensitive conductances (GAmil) were used in the 
present report to express the amount of whole cell conductance that is inhibited by 10 µmol/l 
amiloride. During the whole experiment, the bath was continuously perfused at a rate of 5−10 
ml/min. All experiments were conducted at room temperature (22°C). 
 
Immunoprecipitation and Western blot 
 
Lysates of M1 cells were incubated with a phosphatase inhibitor cocktail 2 (Sigma, St. Louis, 
MO) and PIP2 (10 µM, Sigma) for 30 min and were immunoprecipitated using an anti-PIP2 
antibody (mouse monoclonal IgM, Echelon, San Jose, CA) and protein A/G Plus-agarose 
(Santa Cruz Biotechnology, Santa Cruz, CA). Immunoprecipitates are resolved by 7% SDS-
PAGE, transferred to Hybond-P (Amersham Pharmacia Biotech, Uppsala, Sweden) and 
incubated with rabbit anti-β- or anti-γENaC antibodies (Zymed, South San Francisco, CA). 
Proteins were visualized using a donkey anti-rabbit IgG conjugated to horseradish 
peroxidase and ECL Advance Detection Kit (Amersham Pharmacia Biotech). Yolk-free 
homogenates were prepared three days after injection of cRNA. Pools of 30 oocytes were 
lysed in 500 µl homogenization buffer (1% Elugent C12E6 (Calbiochem, Darmstadt, 
Germany)), 100 mM NaCl, 20 mM Tris (pH 7.6). Lysates were centrifuged three times at 200 
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g for 5 min at 4°C and one time at 20000 g for 30 min at 4°C. Supernatants were mixed with 
loading buffer, and the protein of 12 oocytes was resolved by 7% SDS-PAGE, transferred to 
Hybond-P (Amersham Pharmacia Biotech) and incubated with anti-FLAG M2 monoclonal 
antibody (Sigma). Proteins were visualized using a sheep anti-mouse IgG conjugated to 
horseradish peroxidase and ECL Advance Detection Kit (Amersham Pharmacia Biotech). 
 
Cell culture and transfections 
 
M1 cells were grown at 37°C with 5% CO2 as described previously (47). For transient 
transfections, cells were grown without antibiotics on millicell-CM transwell filters (Millipore). 
Sub-confluent monolayers were transiently transfected with 1 µg of plasmid DNA (PHPLCδ-
GFP, Dynamin-GFP). PHPLCδ-GFP plasmid encoded the PH domain of the phospholipase 
Cδ3, while the Dynamin-GFP plasmid encoded the relatively non-specific PH domain of 
dynamin. Transfection was performed with LipofectAMINE 2000 reagent (Invitrogen, 
Carlsbad, CA), according to the manufacturer’s protocol. The cells were processed two days 
after transfection for use in confocal microscopy analysis. The transfection efficacy was 
typically between 30−40%. All data were obtained in at least three independent experiments 
with cells of different passages (between 15 and 35). 
 
Confocal microscopy 
 
Confluent layers of cells grown on transwell filters were fixed for 30 min at room temperature 
using 4% paraformaldehyde in PBS and followed by quenching using 50 mM NH4Cl in PBS 
for 10 min. The cell membranes were permeabilized using 0.1% saponin/0.1% Triton X-100 
and incubated with either the actin filament staining phalloidin-rhodamine (0.1 M; 
Calbiochem), or non-specific antibody binding was blocked by 0.2% BSA/0.2% fish skin 
gelatin (Sigma) in PBS for 10 min. All transwell filters were washed extensively with PBS 
before mounting using Mowiol (Calbiochem), and confocal immunofluorescence images were 
obtained using a Nikon Eclipse E600 upright microscope with a Bio-Rad Radiance 2000 
confocal scanning system with a × 100 oil-immersion Nikon objective. 
 
Chemiluminescence measurements 
 
Oocytes were incubated for 60 min at 4°C in ND96 media (in mM: 96 NaCl, 2 KCl, 1.8 CaCl2 
· 2 H2O, 1 MgCl2 · 6 H2O, 5 HEPES, 2.5 sodium pyruvate, adjusted to pH 7.5 with NaOH) 
with 1% bovine serum albumin (BSA) to block non-specific binding of antibodies. Afterwards, 
oocytes were incubated for 60 min at 4°C with 1 µg/ml mouse monoclonal anti-FLAG M2 
antibody (clone M2, Sigma-Aldrich, Taufkirchen, Germany) in 1% BSA/ND96, washed eight 
times at 4°C with 1% BSA/ND96, and incubated with sheep anti-mouse IgG peroxidase-
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linked whole antibody (Amersham Biosciences, Freiburg, Germany) diluted 1: 20000 in 1% 
BSA/ND96 for 40 min at 4°C. Then oocytes were washed for 60 min at 4°C in 1% BSA/ND96 
and in ND96 (60 min, 4°C) and placed separately in 50 µl ECL Plus Western Blotting 
Detection Reagents (Amersham Biosciences, Freiburg, Germany). After an incubation period 
of 5 min at room temperature, chemiluminescence was measured in a BioOrbit 1250 
Luminometer (Turku, Finland). The integration period was 1 s, and the results are given in 
millivolts (mV). 
 
Fluorescence measurements 
 
Oocytes were incubated for 60 min at 4°C in ND96 media (in mM: 96 NaCl, 2 KCl, 1.8 CaCl2 
· 2 H2O, 1 MgCl2 · 6 H2O, 5 HEPES, 2.5 sodium pyruvate, adjusted to pH 7.5 with NaOH) 
with 1% bovine serum albumin (BSA) to block non-specific binding of antibodies. Afterwards 
oocytes were incubated for 60 min at 4°C with 1 µg/ml mouse monoclonal anti-FLAG M2 
antibody in 1% BSA/ND96, washed eight times at 4°C with 1% BSA/ND96 and incubated 
with goat anti-mouse IgG1 fluorescein isothiocyanate (FITC)-conjugated (Santa Cruz 
Biotechnology, Heidelberg, Germany) in 1% BSA/ND96 for 60 min at room temperature and 
in the dark. Oocytes were washed for 60 min at room temperature and in the dark in 1% 
BSA/ND96 and then under the same conditions for 60 min in ND96. Images were obtained 
using a Zeiss Axiovert 35 inverted microscope with a × 3.2 objective and digitized with a 
Nikon D100 camera. 
 
Materials and statistical analysis 
 
All used compounds were of highest available grade of purity. Neomycin, wortmannin, 
phenylarsine oxide, phosphatidylinositol-specific phospholipase C from Bacillus cereus, and 
ATP were from Sigma (Taufkirchen, Germany). Edelfosine, R59022 and m-3M3FBS were 
from Calbiochem. The anti-PIP2 antibody was from Echelon. Student’s t-test P values <0.05 
were accepted to indicate statistical significance; n indicates the number of experiments. 
 
Results 
 
Stimulation of purinergic receptors by ATP inhibits amiloride-sensitive Na+ absorption 
 
We examined the inhibition of amiloride-sensitive Na+ absorption (Isc-Amil) during a 20 min 
stimulation of purinergic receptors by ATP (100 µmol/l) in mouse trachea and mouse 
collecting duct cells (M1) in Ussing chamber experiments (Fig. 1A−D). After mounting 
tracheas and M1 monolayers in perfused Ussing chambers, transepithelial voltages (Vte) of –
8.4 ± 2.4 mV (trachea, n=7) and –14.4 ± 1.4 mV (M1, n=12) were measured and equivalent 
short-circuit currents (Isc) were calculated (Fig. 1E and F). Vte and Isc were largely reduced by 
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amiloride (10 µmol/l), an inhibitor of ENaC. Luminal ATP induced transient changes in Vte 
and attenuated Na+ absorption, as demonstrated by the reduced effects of amiloride on Vte 
and Isc. The transient increase in Isc is due to activation of Cl– secretion, which contributes to 
the lumen negative Vte and thus explains why amiloride does not completely block Vte. 
Neomycin is known to bind to PIP2 with high affinity and to inhibit hydrolysis by PLC (72). 
Because biological membranes are relatively impermeable for neomycin, tracheas and M1 
cells were incubated in a buffer with high (5 mmol/l) neomycin concentration for 3 and 24 h, 
respectively. By use of this approach, regulation of the Na+/H+-exchanger NHE1 by PIP2 
could be demonstrated in a previous study (2). Neomycin treatment suppressed amiloride-
sensitive Na+ transport and interfered with inhibitory effects of ATP on Na+ absorption (Fig. 
1E and F). Activation of PLC by binding of ATP to purinergic receptors in airway cells, leads 
to an increase in intracellular Ca2+ and transient activation of Ca2+-dependent Cl– channels 
(143). Inhibition of PLC hydrolysis by neomycin reduced ATP-induced Cl– secretion to 69.9 ± 
14.3 µA/cm2 (n=5), which was 224.7 ± 11.4 µA/cm2 under control conditions (n=7). In 
contrast to mouse trachea, activation of Cl– conductance and thus negative voltage deflection 
by ATP was not observed in M1 cells (Fig. 1C). The transepithelial resistances remained 
largely unaffected by neomycin incubation and were for M1 287.4 ± 31.2 Ωcm2 (control) and 
296.6 ± 37.4 Ωcm2 (Neo) and for the trachea 58.2 ± 13.1 Ωcm2 (control) and 56.1 ± 15.9 
Ωcm2 (Neo). Similar to neomycin, inhibition of Isc-Amil by ATP in mouse trachea was also 
largely attenuated by the selective inhibitor of PLC, edelfosine (ET-18-OCH3; (178), Fig. 1G). 
Moreover, inhibition of PIP2 hydrolysis by edelfosine (3 h, 10 µmol/l) completely blocked the 
inhibitory effects of ATP on Isc-Amil in M1 cells (data not shown). 
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Fig. 1: Stimulation of purinergic receptors by ATP inhibits amiloride-sensitive Na+ absorption 
(Isc-Amil) in mouse trachea (A) and M1 collecting duct cells (C). Continuous recordings of the 
transepithelial voltage (Vte) in a perfused micro-Ussing chamber and effects of amiloride (A; 
10 µmol/l) under control conditions (A, C) and after luminal application of ATP (100 µmol/l) 
(B, D). Effects of ATP after pre-incubation with neomycin (Neo, 5 mmol/l) for 3 h (trachea) 
and 24 h (M1), respectively. Summaries of the inhibitory effects of ATP on Isc-Amil in the 
absence or presence of neomycin (E, F). Significant inhibition of Isc-Amil by ATP (*paired t-test) 
and incubation with neomycin (#unpaired t-test). Incubation of mouse trachea with edelfosine 
(15 min, 10 µmol/l) attenuated the ATP inhibition of Isc-Amil. Significant inhibition of Isc-Amil by 
ATP (*paired t-test). Attenuated effects of ATP on Isc-Amil in the presence of edelfosine 
(#unpaired t-test; G). n, number of experiments. 
 
 
The effects of ATP on epithelial Na+ transport in mouse trachea were reversible upon 
washout of ATP. Thus, within 90 min after removal of ATP, Isc-Amil gradually returned to 
resting values, which is in excellent agreement with previous kinetic analysis of receptor-
activated phosphoinositide turnover (Fig. 2A and B; (68;230)). Phosphatidylinositol 4 (PI4)-
kinase is an essential enzyme of the inositol phosphate cycle necessary for resynthesis of 
PIP2. The PI4 kinase inhibitor wortmannin (10 µmol/l) blocked recovery of ATP inhibition of Isc-
Amil, similar to a recent study with neuronal M currents (Fig. 2B; (68;126;201)). Wortmannin 
reduced Vte from –10.2 ± 1.7 to –5.7 ± 0.9 mV but did not change Rte significantly 44.8 ± 10.2 
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Ωcm2 (before wortmannin) vs. 48.3 ± 11.5 Ωcm2 (after incubation with wortmannin). Thus, 
integrity of the tissue was maintained throughout the experiment. 
 
Moreover, preincubation with wortmannin for 75 min largely reduced basal Isc-Amil and blocked 
inhibitory effects of ATP on Isc-Amil (data not shown). Diacylglycerol kinase is an essential 
enzyme for resynthesis of PIP2. Inhibition of Isc-Amil by ATP in mouse trachea in the presence 
of R59022 (10 µmol/l), an inhibitor of the diacylglycerol kinase, was not reversible upon 90 
min-washout, further supporting a role of PIP2 hydrolysis for inhibition of Na+ absorption (Fig. 
2C; (49)). Because 10 µmol/l wortmannin may also block other enzymes, we tried to block 
the PI4 kinase with phenylarsine oxide (PO; (68)). However, PO (40 µmol/l) damaged the 
tissue irreversibly and was therefore of no use in our study (data not shown). 
 
 
 
Fig. 2: Recovery of the amiloride-sensitive Na+ absorption (Isc-Amil) from inhibition by 
ATP in mouse trachea. A) Summary of Isc-Amil before, and during recovery from luminal 
application of ATP. After 90 min of washout of ATP, Isc-Amil has recovered almost to the same 
level as before application of ATP. B) Summary of experiments demonstrating inhibition of Isc-
Amil by ATP and recovery after 90 min. Application of wortmannin (15 min, 10 µmol/l) reduces 
Isc-Amil and abolishes recovery from ATP inhibition. C) Blocking of the diacylglycerol kinase 
with R59022 (10 µmol/l) reduces the effects of ATP on Isc-Amil and abolishes recovery from the 
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ATP effect. *Significant difference when compared with pre-control (paired t-test). #Significant 
difference when compared with the absence of wortmannin or R59022 (unpaired t-test). n, 
number of experiments. 
 
 
PIP2 hydrolysis and reduced concentration of PIP2 in the luminal membrane inhibits Isc-
Amil 
 
The role of PIP2 in ATP inhibition of Isc-Amil was examined in cells overexpressing the 
pleckstrin homology (PH) domain from PLCδ3 fused to the green fluorescent protein (GFP). 
PLCδ3-GFP binds to PIP2 with high affinity, and thus PIP2 pools can be visualized in living 
cells (219). In contrast, the PH domain of dynamin binds non-selectively to acidic 
phospholipids (240). Thus, a broader cellular staining was expected in cells transfected with 
dynamin-GFP. GFP fluorescence was detected in polarized grown M1 cells transiently 
expressing PLCδ3-GFP or dynamin-GFP. In addition, parallel staining of actin filaments was 
performed using phalloidin-rhodamine. X/Y scans revealed staining of the plasma membrane 
in cells transfected with PLCδ3-GFP, while dynamin-GFP transfected cells demonstrated 
cytosolic GFP fluorescence (Fig. 3A−C). Confocal X/Z scans indicated a predominant 
location of the GFP fluorescence to the luminal membrane in PLCδ3-GFP transfected cells in 
the absence of extracellular ATP (Fig. 3A). When PLCδ3-GFP transfected monolayers were 
pre-incubated with ATP (100 µmol/l, 30 min), GFP fluorescence in the apical membrane was 
reduced, which suggests ATP-induced hydrolysis of luminal PIP2 and thus depletion of apical 
PIP2 pools (Fig. 3B). 
 
We examined the recovery of Isc-Amil from inhibition by ATP in M1 cells transfected with either 
PLCδ3-GFP or dynamin-GFP (128) in Ussing chamber experiments. Baseline Isc-Amil was 
reduced in cells transfected with PLCδ3-GFP but not in dynamin-GFP transfected cells. ATP 
stimulation further reduced Isc-Amil significantly in both dynamin-GFP or PLCδ3-GFP expressing 
cells. In dynamin-GFP transfected cells, Isc-Amil gradually and significantly recovered from 
ATP-dependent inhibition within 90 min-washout, presumably due to time-dependent 
replenishment of apical PIP2 pools (Fig. 3D). In contrast, in tissues transfected by the PLCδ3-
GFP, Isc-Amil did not recover from inhibition by ATP within 90 min, probably due to high-affinity 
binding of PLCδ3-GFP to PIP2 and delayed refilling of apical PIP2 pools (Fig. 3E). 
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Fig. 3: Confocal microscopy of polarized grown M1 mouse collecting duct cells 
transiently transfected with either PLCδ3-GFP cDNA or dynamin-GFP cDNA. Images are 
representative for n=3 experiments for each series. White lines indicate position of the XZ 
scan in the focal plane (XY scan). Actin filaments were stained with phalloidin-rhodamine 
(red). PLCδ3-GFP transfected cells demonstrated staining of the cell membrane (green). A) In 
the absence of ATP, the luminal compartment was stained predominantly. B) Stimulation 
with ATP (20 min, 100 µmol/l) reduced GFP labeling of luminal but not lateral membranes. C) 
GFP fluorescence detected in dynamin-GFP transfected cells. D, E) Summary of amiloride-
sensitive short-circuit currents Isc-Amil in M1 cells expressing PLCδ3-GFP cDNA or dynamin-
GFP, before and after stimulation with ATP (20 min, 100 µmol/l) and during 90 min-washout. 
*Significant inhibition of Isc-Amil by ATP. #Significant recovery from inhibition by ATP (paired t-
test). n, number of experiments. 
 
 
Similar to the results obtained in mouse trachea, the PI4 kinase inhibitor wortmannin (10 
µmol/l; 3 h) reduced Isc-Amil and the short-circuit current that is inhibited by ATP (data not 
shown). Taken together, these results suggest that the inhibitory effect of ATP on Isc-Amil is 
mediated by hydrolysis of PIP2, resulting in a loss of ENaC/PIP2 interaction. 
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Interaction of ENaC with PIP2 
 
The data point out to an interaction of the epithelial Na+ channels with PIP2. PIP2 binding 
motifs have been identified in N termini of β- and γENaC, but not in the α subunit (235). This 
was further examined by immunoprecipitation of lysates isolated from M1 cells, using an anti-
PIP2 antibody (Echelon). Immunoprecipitates were detected by SDS-PAGE and Western 
blotting using rabbit polyclonal anti-β- or anti-γENaC antibodies. Precipitation by PIP2 was 
clearly detectable for βENaC but was less obvious for γENaC (Fig. 4B). As shown in Fig. 4B 
(first lanes), precipitation by endogenous PIP2 (-PIP2) resulted in a weak band only. 
Immunoprecipitation was done in the presence of phosphatase inhibitor in order to avoid 
spontaneous hydrolysis of PIP2. We controlled for possible effects of these inhibitors on 
ENaC in Ussing chamber experiments. As shown in Fig. 4C, application of the phosphatase 
inhibitor did not affect amiloride-sensitive Na+ transport. Moreover, including ATP (1 mmol/l) 
in the buffer used for the immunoprecipitation did not affect the result (data not shown). We 
examined whether ATP-dependent inhibition of ENaC could be demonstrated in Xenopus 
oocytes and thus co-expressed both ENaC and P2Y2 receptors. Stimulation with ATP (100 
µmol/l) activated Ca2+-dependent Cl– channels and increased the whole cell current 
transiently. Activation of P2Y2 receptors also largely reduced amiloride-sensitive currents 
(Fig. 4D). Effects on ENaC currents were not observed in oocytes solely expressing ENaC 
(Fig. 4E). Moreover, hydrolysis of PIP2 and inhibition of ENaC in Xenopus oocytes was 
induced by injecting (1 U in 47 nl) phosphatidylinositol-specific phospholipase C from Bacillus 
cereus and by incubation with the membrane-permeable direct activator of phospholipase C, 
m-3M3FBS (10 µmol/l; (10)). Interfering with PIP2 synthesis by 24 h incubation in wortmannin 
(10 µmol/l), injection of neomycin (1 mol/l, 47 nl), or incubation of oocytes in ND96 solution at 
pH 6.0 (1 h), all reduced GAmil. H2O injection (47 nl) was without effects on GAmil (Fig. 4F). 
Phenylarsine oxide could not be used since it was toxic to oocytes. Taken together, inhibition 
of ENaC by ATP binding to P2Y2 receptors in Xenopus oocytes probably occurs through PIP2 
hydrolysis. 
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Fig. 4: A) Western blot analysis of βENaC and γENaC in M1 cells and B) co-
immunoprecipitation of βENaC and γENaC with PIP2. Cell lysates were immunoprecipitated 
with anti-PIP2 antibody in the absence or presence of exogenous PIP2 (10 µmol/l) and the 
immunoprecipitates resolved on gels and blots detected with subunit-specific ENaC 
antibodies. C) Effect of phosphatase inhibitor on Isc-Amil in mouse trachea. D) Inhibition of 
ENaC by ATP (100 µmol) in Xenopus oocytes co-expressing α,β,γ-wtENaC and the 
purinergic P2Y2 receptor. Original recording showing the effects of ATP and the inhibition of 
the amiloride-sensitive (A, 10 µmol/l) part of the whole cell current (Im). E) Summary of the 
inhibitory effects of ATP on amiloride-sensitive whole cell conductance in ENaC/P2Y2 co-
expressing oocytes but not in oocytes expressing ENaC only. F) GAmil in ENaC expressing 
oocytes before and after treatment: H2O injection (47 nl), injection of phospholipase C (PLC, 
1 U in 47 nl), incubation with the PLC activator m-3M3FBS (10 µmol/l in 47 nl, 30 min), 
injection of neomycin (Neo, 1 mol/l, 47 nl), incubation in wortmannin (10 µmol/l, 47 nl, 25 h) 
and exposure to ND96, pH 6.0 (1 h). *Significant difference when compared with pre-control 
(paired t-test). n, number of experiments. 
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We tried to further verify the importance of the putative PIP2 binding of ENaC. To that end, 
the binding motifs in β- and γENaC were mutated by replacing 2 (β2N, γ2N) or 4 (β4N, γ4N) 
positively charged amino acid residues in the N-terminal PIP2 binding region by non-polar 
amino acids (cf, Fig. 5A). Wild-type and mutant ENaC proteins were expressed in oocytes 
and amiloride-sensitive currents were recorded. Heterotetrameric channels containing 
αwt,βwt,γ2N-ENaC (γ2N) and αwt,βwt,γ4N-ENaC (γ4N) produced currents indistinguishable 
to wild-type currents (αβ,γwt). In contrast, αwt,β2N,γwt-ENaC (β2N) produced amiloride-
sensitive whole cell currents, which were significantly reduced when compared with wild-type 
ENaC. Replacing four charged residues (β4N) almost abolished whole cell currents (Fig. 5).  
 
 
 
Fig. 5: The PIP2 binding domain in βENaC is required for ENaC channel activity. A) 
Amino acid sequence of the putative PIP2 binding domain in βENaC and γENaC and 
generated mutations. B) Original recordings of whole cell currents (Im) in Xenopus oocytes 
expressing α,β,γ-wtENaC or ENaC in which either the β subunit (β2N, β4N) or the γ subunit 
(γ2N, γ4N) have been mutated. Whole cell currents were measured during continuous 
voltage clamp from –90 mV to +30 mV in steps of 10 mV. C) Summary of the calculated 
GAmil. αwt,βwt,γ2N-ENaC (γ2N) and αwt,βwt,γ4N-ENaC (γ4N) produce currents 
indistinguishable from that of α,β,γ-wtENaC. Conductances produced by the double mutant 
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αwt,β2N,γwt-ENaC (β2N) were attenuated and were almost abolished for the quadruple 
mutant αwt,β4N,γwt-ENaC (β4N). *Indicates significant difference from βγwt (unpaired t-test). 
n, number of experiments. 
 
 
Similar results were obtained by expression of only two subunits (Fig. 6A). Reduced current 
amplitudes could be due to impaired PIP2 activation of ENaC, lower surface expression of 
the mutant channels, or simply by reduced expression of β2N and β4N. Using FLAG-tagged 
ENaC subunits (kindly provided by B. Rossier, University of Lausanne, Switzerland), we 
found that expression of FLAG-tagged β2N and β4N were, if at all, enhanced but not reduced 
(Fig. 6B). Whole cell conductances generated by FLAG-tagged subunits were comparable 
with that of the non-flagged subunits (Fig. 6C). Thus, loss of amiloride-sensitive Na+ currents 
by mutating the PIP2 binding domain in βENaC is due to either reduced surface expression 
or lower activity of the channel. 
 
 
 
Fig. 6: Xenopus oocytes expressing FLAG-tagged ENaC. A) Summary of GAmil generated 
by co-expression of only two ENaC subunits (αβENaC or αγENaC) in Xenopus oocytes and 
effects of mutations in βENaC or γENaC. B) Western blot of FLAG-tagged β4N, β2N and βwt 
co-expressed with wt αγENaC in Xenopus oocytes. C) Summary of the calculated amiloride-
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sensitive whole cell conductances (GAmil) generated by co-expression of non-tagged βγ-, αγ-, 
or αβ subunits together with wild-type and mutant FLAG-tagged α β γ subunits. *Indicates 
significant differences from βwt and γwt, respectively (unpaired t-test). n, number of 
experiments. 
 
 
PIP2 binding domain in βENaC controls channel activity rather than surface 
expression 
 
By two different methods we examined whether mutations in the PIP2 binding domain affect 
surface expression in Xenopus oocytes. Ooctyes were injected with FLAG-tagged wild-type 
or mutant ENaC subunits, and currents were measured in double electrode voltage clamp 
experiments. These oocytes were incubated first with a monoclonal anti-FLAG M2 antibody 
and then with a FITC-conjugated goat anti-mouse IgG1. Little FITC fluorescence was 
detected in water-injected oocytes. In contrast, bright FITC fluorescence was detected in all 
oocytes expressing either wt or mutant β- or γ subunits (Fig. 7A). Surface expression was 
quantified by chemiluminescence. After oocytes were incubated with anti-FLAG M2 (clone 
M2, Sigma-Aldrich, Germany) and anti-mouse peroxidase-linked antibodies (Amersham 
Biosciences, Germany), chemiluminescence was measured for 1 s and was expressed in 
millivolts (mV). The signal was larger for the αFLAG-injected oocytes, explained by the two α 
subunits present in the heterotetrameric channel, but was otherwise identical in oocytes 
expressing either wild-type or mutant ENaC. Thus, the reduced Na+ conductance generated 
by PIP2 binding mutants of βENaC is due to reduced channel activity rather than changes in 
surface expression. 
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Fig. 7: A) Detection of surface expression of ENaC subunits by fluorescence labeling of 
ENaC subunits in intact Xenopus oocytes. Bright field images indicating location of the 
oocyte. FLAG-tagged ENaC subunits were detected by staining with primary anti-FLAG and 
secondary FITC-conjugated antibodies. B) Detection of surface expression of ENaC subunits 
by chemiluminescence measurements of intact Xenopus oocytes. FLAG-tagged ENaC 
subunits were detected by staining with primary anti-FLAG and secondary IgG peroxidase-
linked antibodies. Chemiluminescence was integrated over 1 s and is expressed in mV. 
*,#Indicate difference from control and β- or γ FLAG-tagged subunits, respectively (unpaired t-
test). n, number of experiments. 
 
 
In addition, Xenopus oocytes co-expressing FLAG-tagged ENaC subunits together with P2Y2 
were stimulated with ATP (100 µmol/l). As shown in Fig. 8, surface expression of the tagged 
ENaC subunits remained unchanged during activation of the P2Y2 receptor. Thus, purinergic 
inhibition of ENaC currents is due to inactivation of ENaC channels rather than channel 
endocytosis. 
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Fig. 8: Xenopus oocytes co-expressing FLAG-tagged ENaC together with P2Y2. 
Detection of surface expression of ENaC subunits by chemiluminescence measurements of 
intact Xenopus oocytes. FLAG-tagged ENaC subunits were detected by staining with primary 
anti-FLAG and secondary IgG peroxidase-linked antibodies. Stimulation of the oocytes with 
ATP (100 µmol/l, black bars) did not change surface expression. Chemiluminescence was 
integrated over 1 s and is expressed in mV. n, number of experiments. 
 
 
Discussion 
 
A physiologically and pathophysiologically important regulation of ENaC 
 
A role of extracellular ATP as important signalling molecule has been proposed. Luminal 
purinergic receptors along the nephron may control cell volume during solute transport 
(127;194). Compartmentalized autocrine signalling activates Cl– secretion in the respiratory 
tract and is thought to resemble a mechanism to “flush” noxious particles away from airway 
surfaces (90). The present findings may be of potential interest for a novel pharmacological 
approach to cystic fibrosis. In recent years, it has been demonstrated that activation of 
purinergic receptors in airway epithelia by extracellular nucleotides improves mucus 
clearance in CF. This is due to activation of Ca2+-dependent Cl– channels and attenuation of 
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excessive Na+ absorption. Clinical trials are underway to test the effects of synthetic 
purinergic compounds on the progression of lung disease in CF patients (122). The present 
data indicate a strong regulatory impact of PIP2 on ENaC. Thus, compounds that interfere 
with the PIP2 metabolism and deplete airway epithelial cells of PIP2 could be used for 
deactivation of ENaC and inhibition of Na+ absorption. 
 
How is ENaC regulated by PIP2? 
 
Phospholipid regulation of ion channels has unmasked a functional link between membrane 
metabolism and ion channel activity (83). A metabolism-excitation coupling has been 
described for KATP channels, where PIP2 largely controls the nucleotide sensitivity of the KATP 
channel (12;199). Mechanosensitivity of GIRK K+ channels has been shown to be mediated 
by PKC-dependent channel-PIP2 interaction (239). A protein kinase-independent activation of 
CFTR Cl– channels has been found in one but not in another study (83;85). For transient 
receptor potential like (TRPL) channels, inhibitory and activatory effects of PIP2 have been 
found (132). PIP2 activates KATP channels as well as the delayed rectifier potassium channel 
KCNQ1/KCNE1 and KCNQ2/KCNQ3 channels, forming the M current in neuronal cells 
(89;134;238). Incubation of neuronal cells with wortmannin prevented recovery from 
receptor-mediated inhibition of M currents and blocked PIP2 replenishment of the cell 
membrane. Recovery of ENaC currents from ATP inhibition was also abolished after 
treatment with wortmannin, which inhibits conversion of phosphatidylinositol to PI(4)P by the 
PI4 kinase. Similar to that, wortmannin caused a rapid loss of the hormone-sensitive PIP2 
pool after angiotensin II stimulation of glomerulosa cells (167). Thus, the present data 
indicate upregulation of ENaC activity by PIP2, probably due to an increase in the open 
probability of ENaC as suggested earlier (137;235). Further experiments will have to 
elucidate the impact of PIP2 on channel kinetics and may identify a possible stabilization of 
the channel open state, as suggested for both KATP and KCNQ1/KCNE1 channels (61;134). 
 
PIP2 regulation of ENaC in lipid rafts? 
 
The present results trigger the challenging question whether purinergic and thus PIP2-
dependent regulation of ENaC in the luminal membrane of epithelial cells takes place in lipid 
rafts. This is not unlikely because localization of ENaC in cholesterol and PIP2-rich 
microdomains has been shown recently (84). For inhibition of ENaC to take place, PIP2 
hydrolysis should occur in close proximity to the channel, and thus co-localization of ENaC 
and P2Y2 in lipid rafts would offer an ideal platform for receptors/channel interaction. 
Membrane staining by binding of PHPLCδ-GFP to PIP2 in the inner leaflet of non-polarized 
cells has been shown recently (48). PLC activation through ionomycin-induced hydrolysis of 
PIP2 and redistributed GFP fluorescence to the cytosolic compartment (2). The present data 
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show location of PIP2 predominantly in the luminal membrane of polarized M1 epithelial cells 
and suggest emptying of these apical PIP2 pools by stimulation with ATP. PIP2 turnover 
requires permanent resynthesis by ATP-consuming kinases. A rundown of ENaC activity is 
often observed in ENaC expressing oocytes or during patch clamp experiments and inclusion 
of ATP into the patch pipette prevents channel rundown (94;224). This was explained by a 
direct non-hydrolytic action of ATP on ENaC. However, rundown of ENaC activity in the 
absence of ATP may also be explained by dephosphorylation and loss of PIP2 (137). 
 
A binding pocket for PIP2 in ENaC? 
 
PIP2 binding domains from various proteins, including KATP channels, contain a lipid 
interaction domain with conserved structural features. This domain is formed by clustered 
positively charged residues in a β-strand binding pocket, such as formed by the intracellular 
COOH terminus of KATP. It probably mediates electrostatic interaction with the negatively 
charged phosphates of PIP2 (48;57;62;217). However, highly conserved positively charged 
amino acids were also localized in the NH2 terminus of the channel, which are crucial for PIP2 
binding and changes in pH and ATP sensitivity (12;57;62;217). Thus, both NH2 and COOH 
termini participate in the control of KATP channel activity by PIP2. Because similar could hold 
true for the PIP2-dependent regulation of ENaC, we analyzed the distribution of positively 
charged amino acids in β- and γ subunits of ENaC. In fact, COOH termini in both β- and γ 
subunits contain numerous arginine residues, which could serve as potential sides for PIP2 
interaction. In additional experiments we generated COOH truncation mutants of β (βV561X, 
βR561X)- and γ (γS608X, γR565X) ENaC but found no change in amiloride-sensitive whole 
cell currents after expression in Xenopus oocytes (unpublished from the author’s laboratory). 
 
According to our data, the N terminus of γENaC does not participate in PIP2-dependent 
regulation. Moreover γENaC was only weakly co-immunoprecipitated by PIP2. Lack of 
importance of γENaC for PIP2-dependent regulation is further supported by chimeric subunit, 
in which the initial 95 amino acids in the N terminus of γENaC were replaced by the N 
terminus of αENaC. This α/γ chimera produced normal ENaC currents upon co-expression 
with α- and β subunits. In contrast, elimination of the N terminus in βENaC abolished Na+ 
currents almost completely (unpublished from the author’s laboratory). These results suggest 
that PIP2-dependent regulation of ENaC is limited to the putative PIP2 binding side in the NH2 
terminus of βENaC. Thus, the COOH terminus of ENaC determines surface expression of 
the channel, whereas the NH2 terminus regulates channel activity, probably by controlling the 
single channel open probability. 
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Chapter 3 
 
 
Cl− interference with the epithelial Na+ channel ENaC 
 
Abstract 
 
The cystic fibrosis transmembrane conductance regulator (CFTR) is a protein kinase A and 
ATP-regulated Cl− channel that also controls the activity of other membrane transport proteins, 
such as the epithelial Na+ channel ENaC. Previous studies demonstrated that cytosolic 
domains of ENaC are critical for downregulation of ENaC by CFTR, while others suggested a 
role of cytosolic Cl− ions. We therefore examined in detail the anion-dependence of ENaC and 
the role of its cytosolic domains for the inhibition by CFTR and the Cl− channel CLC-0. Co-
expression of rat ENaC with human CFTR or the human Cl− channel CLC-0 caused inhibition 
of amiloride-sensitive Na+ currents after cAMP-dependent stimulation and in the presence of a 
100 mM bath Cl− concentration. After activation of CFTR by 3-isobutyl-1-methylxanthine and 
forskolin or expression of CLC-0, the intracellular Cl− concentration was increased in Xenopus 
oocytes in the presence of a high bath Cl− concentration, which inhibited ENaC without 
changing surface expression of αβγENaC. In contrast, a 5 mM bath Cl− concentration reduced 
the cytosolic Cl− concentration and enhanced ENaC activity. ENaC was also inhibited by 
injection of Cl− into oocytes and in inside/out macropatches by exposure to high cytosolic Cl− 
concentrations. The effect of Cl− was mimicked by Br−, NO3− and I−. Inhibition by Cl− was 
reduced in trimeric channels with a truncated COOH terminus of βENaC and γENaC, and it 
was no longer detected in dimeric α∆Cβ ENaC channels. Deletion of the NH2 terminus of α-, 
β-, or γENaC, mutations in the NH2-terminal phosphatidylinositol-bisphosphate binding domain 
of βENaC and γENaC and activation of phospholipase C, all reduced ENaC activity but 
allowed for Cl−-dependent inhibition of the remaining ENaC current. The results confirm a role 
of the carboxyl terminus of βENaC for Cl−-dependent inhibition of the Na+ channel, which, 
however, may only be part of a complex regulation of ENaC by CFTR. 
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Introduction 
 
The cystic fibrosis transmembrane conductance regulator (CFTR) is a cAMP-regulated Cl− 
channel and a regulator of other channels. A large number of membrane proteins and 
cellular processes are reported to be controlled by CFTR (117;193). Most work has been 
devoted to the inhibitory effect of CFTR on the epithelial Na+ channel ENaC. Missing 
inhibition of ENaC by defective CFTR in cystic fibrosis (CF) is regarded as an important 
reason for the enhanced epithelial Na+ conductance detected in the airways of CF patients 
(31;120;138). A regulatory relationship has been shown for CFTR and ENaC in human and 
murine airway and intestinal epithelia (138;139), and enhanced Na+ absorption has been 
demonstrated in airways and colonic epithelia carrying the CF defect (31). Subsequent 
studies showed that the epithelial Na+ channel is inhibited in recombinant and native cells 
during activation of CFTR (34;95;98;111;129;138;139;142;210).  
 
Studies were performed to uncover the mechanism of the reciprocal interaction between 
CFTR and ENaC. Two-hybrid analysis and co-immunoprecipitation suggested a direct 
molecular interaction between CFTR and αENaC, and the first nucleotide binding domain of 
CFTR was found to be crucial for inhibition of ENaC (97;121;191). Another study found a role 
of the carboxyl terminus of βENaC for downregulation of ENaC by activation of CFTR in 
Xenopus oocytes (97). When CFTR and ENaC were reconstituted in a cell-free planar lipid 
bilayer, carboxyl-terminal domains of β- and γENaC were found to modulate the kinetics of 
the channel, whereas the NH2 terminus β- and γENaC were in charge of CFTR-dependent 
regulation of heterodimeric αβ- and αγENaC but not in heterotrimeric αβγENaC (18). We and 
others found that truncations or Liddle's disease mutations in the COOH terminus of α-, β- 
and γENaC do not abolish CFTR-dependent inhibition of ENaC in trimeric channels (86;110). 
However, the COOH-terminal 20 amino acid residues of αENaC conferred species specificity 
of ENaC inhibition by CFTR in another study (231). Most studies agreed that CFTR affects 
ENaC channel kinetics and open probability rather than surface expression of ENaC 
(18;97;110). For mutant CFTR, which is unable to inhibit ENaC, genistein was shown to 
restore the functional interaction between CFTR and ENaC (142;211;212). Interestingly, the 
reverse namely an upregulation of CFTR currents by ENaC co-expression, has also been 
observed (98;111).  
 
Possible contributions by additional proteins and factors to the CFTR regulation of ENaC has 
been examined in subsequent studies. CFTR carries a so-called PDZ-binding domain, a 
common site for protein interaction at the COOH terminus, which binds regulatory proteins 
such as NHERF (225). This PDZ domain is essential for proper expression of CFTR in the 
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apical plasma membrane of polarized cells (162;163). Whereas in Xenopus oocytes this 
domain was neither important for expression of CFTR nor for inhibition of ENaC by CFTR, in 
polarized epithelial cells NHERF affects expression of both CFTR and ENaC (33;190). Other 
mechanisms were excluded, such as release of ATP by CFTR, followed by purinergic 
inhibition of ENaC (108). Also changes in cell volume, which may occur during activation of 
Cl− conductances, are unlikely to explain the negative effects of CFTR on ENaC (192). 
However, independent reports demonstrated a role of Cl− ions (97;109). It has known for 
some time that Na+ and Cl− conductances are controlled by the cytosolic Cl− concentration in 
intralobular duct cells of the mouse mandibular gland (54). Subsequent studies demonstrated 
that the control of ENaC currents by intracellular anions is mediated by G proteins in salivary 
duct cells, but not in Xenopus oocytes (53;91). Different mechanisms have been shown for 
inhibition of ENaC by cytosolic Na+ and Cl− (107). Our initial work suggested that influx of Cl− 
into the oocyte rather than the efflux is inhibiting ENaC (34). Although a role of Cl− for the 
inhibition of ENaC by CFTR was not found in all studies (42;110), subsequent work in both 
epithelial tissues and Xenopus oocytes confirmed that intracellular Cl− ions decrease 
expression of ENaC protein (169) and acutely inhibit ENaC currents (97;109;190;229). 
Recent studies with polarized epithelial cells expressing ENaC along with CFTR and Ca2+-
activated Cl− channels, demonstrate an increase in intracellular Cl− by stimulation of CFTR or 
Ca2+-dependent Cl− channels (1). This increase in intracellular Cl− is paralleled by inhibition of 
amiloride-sensitive Na+ conductance. Amiloride-sensitive Na+ currents are also inhibited in 
patch clamp experiments, when high Cl− concentrations are present on the cytosolic side 
(1;190). These results strongly suggest a role of Cl− ions for inhibition of ENaC by CFTR or 
other Cl− channels. These channels cause an increase in the intracellular Cl− concentration 
when a large parallel Na+ conductance is present (118). We therefore tried in the present 
study to identify a Cl−-sensitive side in ENaC. We found that amino and carboxyl termini of α-
, β-, and γENaC control ENaC activity and show a role of the COOH terminus of βENaC for 
inhibition by Cl−. 
 
Material and Methods 
 
Ussing chamber experiments 
 
Mouse M1 collecting duct cells were grown to confluence on permeable supports and were 
mounted into a modified Ussing chamber with a circular aperture of 0.95 mm2. M1 cells are 
derived from mouse cortical collecting duct and have properties of principal cells (kindly 
provided by C. Korbmacher, Physiologisches Institut, Universität Erlangen, Germany). Luminal 
and basolateral sides of the epithelium were perfused continuously at a rate of 10 ml/min 
(chamber volume 2 ml). The bath solution had the following composition (mmol/l): NaCl 145, 
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KH2PO4 0.4, K2HPO4 1.6, D-glucose 5, MgCI2 1, HEPES 5, Ca-gluconate 1.3. pH was 
adjusted to 7.4. Bath solutions were heated to 37°C using a water jacket. Experiments were 
carried out under open-circuit conditions. Values for transepithelial voltages (Vte) were referred 
to the serosal side of the epithelium. Transepithelial resistance (Rte) was determined by 
applying short (1 s) current pulses (∆l=0.5 µA) and the resistance of the empty chamber was 
subtracted. Rte was calculated according to Ohm's law (Rte=∆Vte/∆I). The equivalent short-
circuit current (Isc) was calculated (Isc=Vte/Rte) and the amiloride-sensitive Isc (Isc-Amil) is used to 
express the amount of equivalent short-circuit current that is inhibited by 10 µmol/l amiloride. 
Tissue preparations were only accepted if the transepithelial resistance exceeded that of an 
empty chamber at least by a factor of 3. The transepithelial resistance of filter grown M1 cells 
was 387 ± 39 Ωcm2 (n=20).  
 
cRNAs for ENaC subunits, CFTR and CLC-0 and ENaC mutants 
 
cDNAs encoding rat αβγENaC (kindly provided by Prof. Dr. B. Rossier, Pharmacological 
Institute of Lausanne, Switzerland) and the Cl− channels CFTR or CLC-0 were linearized in 
pBluescript or pTLN (105) with Notl or Mlul, and in vitro transcribed using T7, T3 or SP6 
promotor and polymerase (Promega, USA). For some experiments cDNAs of FLAG-tagged 
αβγENaC subunits were used (kindly provided by Prof. B. Rossier, University of Lausanne, 
Switzerland) (67). Isolation and microinjection of oocytes have been described in a previous 
report (142). In brief, after isolation from adult Xenopus laevis female frogs (Xenopus express, 
South Africa and Kähler, Germany), oocytes were dispersed and defolliculated by a 45 min-
treatment with collagenase (type A, Boehringer, Germany). Subsequently, oocytes were rinsed 
and kept at 18°C in NMDG/ND96 buffer (in mmol/l): NMDG 96, HCl 80, KCI 2, CaCI2 1.8, 
MgCI2 1, HEPES 5, sodium pyruvate 2.5, pH 7.55, supplemented with theophylline (0.5 
mmol/l) and gentamycin (5 mg/l). Mutations in the NH2-terminal phosphatidylinositol-
bisphosphat PIP2 binding domains of β- and γENaC were generated by replacing 2 (β2N, γ2N) 
and 4 (β4N, γ4N) positively charged amino acids by non-polar (N) amino acids as described in 
Ref. 119. α∆N, β∆N and γ∆N indicate that the NH2 terminus of α-, β-, and γ subunits was 
shortened by removing the first 94, 50, and 94 initial amino acids, respectively, and in some 
cases replaced by other N-terminal subunits (116). All other mutations and truncations 
(αP671A, α∆C=αH647X, β∆C=βR561X and βV554X, γ∆C=γS608X and γR565X) have been 
generated by PCR techniques and correct sequences were verified by sequencing. 
 
Double electrode voltage clamp 
 
Oocytes were injected with cRNA (1−10 ng) after dissolving in 47 nl double-distilled water 
(Nanoliter Injector WPI, Germany). Water-injected oocytes served as controls. 2−4 days after 
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injection, oocytes were impaled with two electrodes (Clark instruments) that had a resistance 
of <1 MΩ when filled with 2.7 mol/l KCI. Using two bath electrodes and a virtual-ground 
headstage, the voltage drop across Rserial was effectively zero. Membrane currents were 
measured by voltage clamping of the oocytes (Warner oocyte clamp amplifier OC725C) in 
intervals from –90 to +30 mV, in steps of 10 mV, each 1 s. Conductances were calculated 
according to Ohm's law and amiloride-sensitive conductances (GAmil) were used in the present 
report to express the amount of whole cell conductance that is inhibited by 10 µmol/l amiloride. 
During the whole experiment, the bath was continuously perfused at a rate of 5−10 ml/min. All 
experiments were conducted at room temperature (22°C). 
 
Chemiluminescence measurements 
 
Oocytes were incubated for 60 min at 4°C in ND96 media (in mM: 96 NaCl, 2 KCl, 1.8 CaCl2 
· 2 H2O, 1 MgCl2 · 6 H2O, 5 HEPES, 2.5 sodium pyruvate, adjusted to pH 7.5 with NaOH) 
with 1% bovine serum albumin (BSA) to block non-specific binding of antibodies. Afterwards 
oocytes were incubated for 60 min at 4°C with 1 µg/ml mouse monoclonal anti-FLAG M2 
antibody (clone M2, Sigma) in 1% BSA/ND96, washed eight times at 4°C with 1% 
BSA/ND96, and incubated with sheep anti-mouse IgG peroxidase-linked whole antibody 
(Amersham Biosciences) diluted 1:20000 in 1% BSA/ND96 for 40 min at 4°C. Then oocytes 
were washed for 60 min at 4°C in 1% BSA/ND96 and in ND96 (60 min, 4°C) and placed 
separately in 50 µl ECL Plus Western Blotting Detection Reagents (Amersham Biosciences). 
After an incubation period of 5 min at room temperature, chemiluminescence was measured 
in a BioOrbit 1250 Luminometer (Turku, Finland). The integration period was 1 s and the 
results were obtained in millivolts (mV). 
 
Fluorescence measurements 
 
Oocytes were incubated for 60 min at 4°C in ND96 media (in mM: 96 NaCl, 2 KCl, 1.8 CaCl2 
· 2 H2O, 1 MgCl2 · 6 H2O, 5 HEPES, 2.5 sodium pyruvate, adjusted to pH 7.5 with NaOH) 
with 1% BSA to block non-specific binding of antibodies. Afterwards oocytes were incubated 
for 60 min at 4°C with 1 µg/ml mouse monoclonal anti-FLAG M2 antibody in 1% BSA/ND96, 
washed eight times at 4°C with 1% BSA/ND96 and incubated with goat anti-mouse IgG1 
fluorescein isothiocyanate (FITC)-conjugated (Santa Cruz Biotechnology) in 1% BSA/ND96 
for 60 min at room temperature and in the dark. Oocytes were washed for 60 min at room 
temperature and in the dark in 1% BSA/ND96 and then under the same conditions for 60 min 
in ND96. Images were obtained using a Zeiss Axiovert 35 inverted microscope with a × 3.2 
objective and digitized with a Nikon D100 camera. 
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Macropatch 
 
Xenopus oocytes expressing ENaC were defolliculated and were placed on the stage of an 
inverted microscope (IM35, Zeiss, Oberkochen, Germany). The bath was continuously 
perfused with Ringer solution at a rate of about 10 ml/min. Patch clamp experiments were 
performed in cell-excised inside/out and outside/out configurations. The patch pipettes had 
an input resistance of 2−4 MΩ when filled with a solution containing (mmol/l) 96 NaCl, 2 KCl, 
1.8 CaCl2 · 2 H2O, 1 MgCl2 · 6 H2O, 5 HEPES, 2.5 sodium pyruvate, 1 diphenylcarboxylate at 
pH 7.5. Currents (voltage clamp) and voltages (current clamp) were recorded using a patch 
clamp amplifier (EPC 9, HECA, Lambrecht, Germany) and data were stored continuously on 
a computer hard disc. In regular intervals, membrane voltages (Vc) were clamped in steps of 
10 mV from –50 mV to +50 mV. G was calculated from the measured I and Vc values 
according to Ohm's law. 
 
Materials and statistical analysis 
 
All compounds were of highest available grade of purity. Nystatin, amiloride, NMDG, PIP2, 
phosphatidylinositol-specific phospholipase C from Bacillus cereus and ATP were from Sigma. 
U73122 was from Calbiochem. The anti-PIP2 antibody was from Echelon. Student’s t-test P 
values <0.05 were accepted to indicate statistical significance. n indicates the number of 
experiments. 
 
Results 
 
Whole cell currents produced by the epithelial Na+ channel ENaC were partially inhibited by 
activation of CFTR through stimulation with IBMX (1 mmol/l) and forskolin (2 µmol/l). Inhibition 
was reversible when extracellular (bath) Cl− concentration was reduced from 100 to 5 mM. 
This is shown as a continuous whole cell current recording of an oocyte co-expressing CFTR 
and ENaC (Fig. 1A) and is summarized in Fig. 1B. In oocytes expressing ENaC only, the 
amiloride-sensitive conductance (GAmil) of 59.2 ± 7.9 microsiemens was not changed when the 
extracellular Cl− concentration was reduced to 5 mmol/l (GAmil=59.9 ± 8.2 µS; n=9). All 
experiments were performed using a bath clamp, which minimizes voltage drops along the 
series resistances. However, we included two sets of control experiments. (i) We 
permeabilized ENaC expressing oocytes with 10 µM nystatin, which induced a non-selective 
conductance without affecting amiloride-sensitive membrane currents (Fig. 1D). GAmil was 19.3 
± 2.7 and 23.3 ± 3 µS (n=7) in the absence and presence of nystatin, respectively. (ii) ENaC 
was co-expressed with KVLQT1 K+ channels, and amiloride-sensitive currents were assessed 
in the absence or presence of the K+ channel blocker Ba2+ (5 mM), which did not affect Na+ 
transport (Fig. 1E): GAmil was 7.9 ± 1.3 and 7.5 ± 1.1 µS (n=9) in the absence and presence of 
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Ba2+, respectively. Thus, additional currents do not compromise the measurement of ENaC 
currents in our setup. Cl− currents generated by CFTR but not non-selective currents or K+ 
currents inhibited ENaC.  
 
 
 
Fig. 1: CFTR inhibits ENaC in Xenopus oocytes. A) Original recording of the whole cell 
current in a Xenopus oocyte co-expressing rat αβγENaC together with human CFTR. Whole 
cell currents were measured during continuous voltage clamp from –90 mV to +30 mV in 
steps of 10 mV. CFTR Cl− currents were activated by IBMX/forskolin (1 mM/2 µM) and were 
measured in the presence of a high (100 mM) or low (5 mM) bath Cl− concentration. The 
effects of amiloride (A, 10 µM) on whole cell currents were largely inhibited after activation of 
CFTR and in the presence of high bath Cl− concentration. B) Summary of the effects of 
IBMX/forskolin (I/F) on amiloride-sensitive conductance (GAmil) in co-expressing oocytes. C) 
Typical current/voltage relationships of co-expressing oocytes before and after stimulation 
with IBMX/forskolin and the effect of amiloride. D) Original recording of the whole cell current 
in an ENaC expressing oocyte and the effect of amiloride before and after inducing a non-
selective conductance with nystatin (10 µM). E) Original recording of the whole cell current in 
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a Xenopus oocyte co-expressing rat αβγENaC together with human KVLQT1 K+ channels. 
*Indicates significant difference (paired t-test). n, number of experiments. 
 
 
We examined the Cl−-dependence of the CFTR effect on ENaC in more detail and found that 
in oocytes, in which CFTR had been activated by IBMX/forskolin, a gradual increase in the 
bath Cl− concentration from 2 to 100 mM, gradually inhibited ENaC currents, in parallel to the 
increase of CFTR Cl− currents (Fig. 2A and C). Moreover, we co-expressed the Cl− channel 
CLC-0 together with ENaC and found a comparable decrease of ENaC currents with 
increasing bath Cl− concentrations (Fig. 2B and D). Thus, Cl− ions play an essential role in 
both CFTR, and CLC-0 induced inhibition of ENaC. When ENaC was inhibited by amiloride, 
oocyte membranes are dominated by a Cl− conductance. Thus it is possible to measure the 
Cl− diffusion potential and to calculate for the apparent intracellular Cl− concentration. We 
found that in the presence of activated CFTR or when CLC-0 was co-expressed, increase in 
bath Cl− from 5 to 100 mM resulted in a change of the apparent intracellular Cl− concentration 
from about 10 to roughly 60 mM (Fig. 2E and F). In parallel, ∼ 50% of the initial amiloride-
sensitive Na+ current was inhibited, indicating that an increase in cytosolic Cl− inhibits ENaC. 
We observed a recovery of amiloride-sensitive conductances over the time course of 30 min, 
when bath Cl− was reduced from 100 to 5 mM in ENaC/CLC-0 co-expressing oocytes. Finally, 
injection of 23 nl of 50 mM NaCl also inhibited ENaC, whereas injection of water or 5 mM NaCl 
had no effect (data not shown). In summary, increase in intracellular Cl− inhibits ENaC, which 
may be in charge of the inhibitory effects of CFTR or CLC-0 on ENaC. 
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Fig. 2: Cl−-dependent inhibition of ENaC by CFTR and CLC-0. Original recording of the 
whole cell current in Xenopus oocytes co-expressing αβγENaC together with CFTR (A) or 
CLC-0 (B). Whole cell currents were measured during continuous voltage clamp from –90 
mV to +30 mV in steps of 10 mV. CFTR Cl− currents were activated by IBMX/forskolin (1 
mM/2 µM). Inhibition of whole cell currents by amiloride (A, 10 µM) was examined in the 
presence of bath Cl− concentrations ranging from 2 to 100 mM. Summary of the CFTR (C) 
and CLC-0 (D) induced whole cell conductances and amiloride-sensitive whole cell 
conductances at different bath Cl− concentrations. Relationship between amiloride-sensitive 
whole cell conductance and calculated intracellular Cl− concentration in CFTR (E) and CLC-0 
(F) expressing oocytes. *Indicates significant difference (paired t-test). n, number of 
experiments. 
 
 
This was further confirmed in experiments with macropatches from ENaC expressing oocytes, 
after verifying expression by double electrode voltage clamp. Patch pipettes were filled with 1 
mM diphenylcarboxylate, to minimize endogenous Cl− currents. A current noise was recorded 
from excised inside/out macropatches, which was largely increased when the cytosolic Cl− 
concentration was reduced from 100 to 5 mM (Fig. 3A and B). 95 mM Na+ were replaced by 
NMDG+ in the presence of low or high bath Cl−. We found that the NMDG+ that inhibited Na+ 
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conductance in macropatches was 86.2 ± 6.2 µS in the presence of 5 mM cytosolic Cl−, which 
was significantly larger when compared with that observed at 100 mM Cl− (27.3 ± 2.1 µS). We 
then exposed the cytosolic side of the macropatches to different Cl− concentrations, ranging 
from 5 to 100 mM. As shown in Fig. 3B, a gradual increase in cytosolic Cl− inhibited the 
conductance of excised inside/out membrane patches. Finally, we confirmed expression of 
ENaC in excised outside/out patches and found inhibition of membrane conductance by 
amiloride (10 µM) from 228 ± 70 to 140 ± 60 µS (n=5). Thus ENaC may be directly inhibited by 
Cl− ions or attached Cl−-sensitive proteins control ENaC activity.  
 
 
 
Fig. 3: Cl−-dependent inhibition of ENaC in macropatches. A) Current noise in an 
inside/out macropatch of an ENaC expressing oocyte at different clamp voltages and in the 
presence of high (100 mM) or low (5 mM) cytosolic Cl− concentration. B) Cl−-dependence of 
the conductance of inside/out macropatches of ENaC expressing oocytes. C) Current/voltage 
relationships of the current noise in inside/out macropatches of ENaC expressing oocytes in 
the presence of low or high cytosolic Cl− concentration. n, number of experiments. 
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We examined if the change in cytosolic Cl− affects membrane expression of ENaC. To that 
end, we expressed FLAG-tagged ENaC subunits together with CFTR or CLC-0 and exposed 
the oocytes to 5 or 100 mM bath Cl− concentration. For these experiments CFTR had been 
pre-activated by IBMX and forskolin. FLAG-tagged ENaC subunits were detected by staining 
with primary anti-FLAG and secondary fluorescein isothiocyanate-conjugated antibodies. 
There was no obvious change in fluorescence during exposure to high or low extracellular Cl− 
(data not shown). We quantified surface expression of individual ENaC subunits by 
chemiluminescence and found no change in membrane expression in ENaC/CFTR (Fig. 4A) 
or ENaC/CLC-0 (Fig. 4B) co-expressing oocytes, during change of the bath Cl− concentration 
from 5 to 100 mM Cl−. Chemiluminescence was also measured for βENaC and γENaC 
mutants, in which 2 (β2N, γ2N) or 4 (β4N, γ4N) positively charged amino acids in the NH2 
terminus have been replaced by neutral amino acids. These amino acids are located in PIP2 
binding sides of βENaC and γENaC and control ENaC activity (119;137;235). However, 
membrane expression of the mutant ENaCs was not affected by changes in the bath Cl− 
concentration (Fig. 4A and B). 
 
 
 
Fig. 4: Expression of FLAG-tagged ENaC subunits. A) Detection of surface expression of 
ENaC subunits by chemiluminescence in ENaC/CFTR (A) or ENaC/CLC-0 (B) co-expressing 
oocytes. FLAG-tagged ENaC subunits were detected by staining with a primary anti-FLAG 
and secondary IgG peroxidase-linked antibody. Chemiluminescence was integrated over 1 s 
and is expressed as surface expression relative to that of αENaC at 100 mM Cl−. 
Chemiluminescence was assessed in a bath solution containing 100 mM (black bars) or 5 
mM (white bars) Cl−. β2N, γ2N and β4N, γ4N indicate that 2 or 4 positively charged amino 
acids have been removed from the NH2 terminus of either βENaC or γENaC. The number of 
experiments was for each series between 5 and 15. 
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To further validate the chemiluminescence methods used here, we expressed FLAG-tagged 
ENaC subunits, which were truncated at the COOH terminus of either βENaC (R561X, β∆C) or 
γENaC (S608X, γ∆C). These truncations have been shown to lead to enhanced membrane 
expression of ENaC. In fact, expression of β∆C and γ∆C was enhanced 1.70 ± 0.2 (n=15)- and 
1.73 ± 0.3 (n=15)-fold, respectively, when compared to wt βENaC and wt γENaC. Moreover, 
when β∆C and γ∆C were co-expressed together with CLC-0 or CFTR, membrane expression 
was not affected by a change of bath Cl− from 5 to 100 mM (n=15 for all series, data not 
shown). 
 
The role of Cl− for inhibition of ENaC was further confirmed by blocking CLC-0 channels with 
500 µM Zn2+ (44). Zn2+ inhibited about 50% of the CLC-0 conductance in 100 mM extracellular 
Cl− and enhanced amiloride-sensitive conductance (18.3 ± 4.3 vs. 26.3 ± 4.5 µS). Zn2+ applied 
in a low bath Cl− concentration abolished CLC-0 conductance completely and further 
enhanced ENaC conductance (29.1 ± 4.4 µS, n=9). Zn2+ itself had no effects on ENaC. We 
examined if the effect of Cl− on ENaC can be mimicked by other anions and therefore replaced 
bath Cl− by equimolar concentrations of NO3−, I−, or Br− (Fig. 5A). CFTR conductance and 
inhibition of ENaC were detected in the presence of the different anions, but were both 
reduced in the presence of extracellular I− (Fig. 5B and C). ENaC is inhibited by increase in 
intracellular Na+ (54). This was reported as feedback inhibition and is abolished by ENaC 
mutations occurring in Liddle's disease (86). Since both intracellular Cl− and Na+ may change 
in parallel, we examined if Cl−-dependent inhibition of ENaC is also observed with ENaC 
carrying Liddle's disease mutations or truncations in the COOH terminus of all three subunits 
(Fig. 5D and E). The ENaC mutants were co-expressed either with CFTR (Fig. 5D) or with 
CLC-0 (Fig. 5E). The summaries show that the mutant channels were also inhibited by Cl− in a 
concentration-dependent manner, although inhibition appeared somewhat reduced when 
compared with wtENaC. Thus, Cl−-dependence can be clearly separated from Na+-dependent 
inhibition.  
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Fig. 5: Anion-dependent inhibition of ENaC. A) Original recording of the whole cell current 
in an oocyte co-expressing ENaC and CFTR and the effect of amiloride in the presence of 
different anions in the bath. Summary of the CFTR conductance (B) and inhibition of 
amiloride-sensitive Na+ conductance (C) in the presence of different anions in the bath. D) 
Summary of the CFTR conductance and inhibition of little mutants of the amiloride-sensitive 
Na+ channel in the presence of different bath Cl− concentrations. E) Summary of the CLC-0 
conductance and inhibition of little mutants of the amiloride-sensitive Na+ channel in the 
presence of different bath Cl− concentrations. *Indicates significant difference (paired t-test). 
n, number of experiments. 
 
 
ENaC is inhibited by CFTR and by stimulation of puringeric receptors with ATP or UTP, which 
leads to hydrolysis of PIP2 via activation of phospholipase Cβ (119). We previously found a Cl−-
dependence also for purinergic inhibition of ENaC (123) and therefore asked whether both 
mechanisms are additive. To that end, we measured Na+ absorption in polarized epithelial 
cells of the collecting duct, which express CFTR, ENaC and Ca2+-activated Cl− channels along 
with purinergic receptors. ENaC was shown to be controlled by CFTR and purinergic receptors 
in these cells (47;119;129). In Ussing chamber experiments we observed attenuation of 
amiloride-sensitive transport after activation of CFTR by IBMX and forskolin, indicating 
inhibition of ENaC by CFTR (Fig. 6A). After pre-inhibition of ENaC by purinergic stimulation, 
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the amiloride-sensitive short-circuit current was further reduced by 1.6 ± 0.3 µA/cm2 when 
CFTR was activated. This, however, was significantly less than inhibition of ENaC by CFTR 
without purinergic pre-stimulation (3.9 ± 0.4 µA/cm2, n=6). Moreover when phospholipase Cβ 
was inhibited by U73122 (10 µM), inhibition of amiloride-sensitive transport by CFTR was 
significantly enhanced (7.8 ± 0.9 µA/cm2, n=8). This data suggest that both inhibitory 
mechanisms are additive. The NH2 terminus of β- and γENaC play a central role for the 
purinergic regulation of ENaC and may also participate in CFTR and Cl−-dependent control of 
ENaC. We examined this issue in ENaC and CLC-0 expressing Xenopus oocytes and 
performed maneuvers, which have been shown to affect PIP2 binding and thus ENaC activity 
(119). Injection of PIP2 (30 µM, 30 nl) slightly but significantly enhanced amiloride-sensitive 
whole cell currents. This additional current was inhibited by increase in intracellular Cl− (Fig. 
6B). Control injection of oocytes with water had no effects. In contrast, injection of a PIP2 
antibody (1:100, 30 nl) slightly reduced GAmil and the remaining current was inhibited by Cl− to 
the same level as before injection (Fig. 6C). Moreover, both injection of phospholipase Cβ (2 
U/mg, 30 nl) or incubation of the oocytes in pH 6.0 for 1 h largely reduced GAmil and the 
amount of GAmil blocked by Cl− (Fig. 6D and E). These results suggest that PIP2 binding of β- 
and probably γENaC determines the amount of ENaC current inhibited by Cl− ions.  
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Fig. 6: Inhibition of ENaC by ATP and Cl−. Continuous recording of the transepithelial 
voltage (Vte) of M1 collecting duct cells in a perfused micro-Ussing chamber and effects of 
amiloride (A; 10 µmol/l) under control conditions and after activation of CFTR by IBMX and 
forskolin. B−E) Change in the intracellular Cl− concentration [Cl−]i by an increase in the bath 
Cl− concentration from 5 to 100 mM in CLC-0/ENaC co-expressing oocytes and change in 
the amiloride-sensitive Na+ conductance. Effects of injection of PIP2 (23 nl, 25 µM, n=16) (B), 
injection of PIP2 antibody (23 nl, 1:100, n=6) (C), injection of PLC (23 nl, 2 U/ml, n=9) (D) or 
incubation for 30 min at pH 6.0; n=26 (E). Dashed lines indicate inhibition of ENaC by 
increase in [Cl−]i in control oocytes (n=10−26). *Indicates significant difference (paired t-test). 
#Indicates significant difference in Na+ conductance and slope for Cl−-dependent inhibition 
(unpaired t-test).  
 
 
We further tried to identify the ENaC subunits and cytosolic domains that participate in Cl−-
dependent regulation. To that end, αβγ subunits were truncated at amino (∆N) or carboxyl 
(∆C) termini and co-expressed in various combinations. Moreover, PIP2 binding domain 
mutants of β- and γENaC were generated by eliminating 2 or 4 positively charged amino acids 
(β2N, β4N, γ2N, γ4N) (119). ENaC subunits were co-expressed together with CLC-0 or CFTR, 
activated with IBMX and forskolin. The whole cell currents generated by CLC-0 or CFTR in the 
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presence of 100 mM extracellular Cl− were between 5 and 10 µA and were reduced by 
replacing extracellular Cl− by gluconate (data not shown). Because virtually identical results 
were obtained for co-expression of ENaC with CLC-0 and CFTR and for αwt, α∆C, αP671A, 
the data are not listed separately. Fig. 7A shows the ratio of GAmil generated by mutant ENaC 
to GAmil produced by wtENaC at low (5 mM) bath Cl− (black bars). The white bars indicate the 
ratio of the inhibition of mutant ENaC to inhibition of wtENaC by an increase in bath Cl− to 100 
mM (white bars). It is shown that individual truncations (∆C) of the carboxyl terminus of α-, β-, 
and γENaC in trimeric channels lead to enhanced Na+ currents compared with wtENaC, but 
attenuated downregulation by Cl− only for β∆C. Interestingly, the double mutant β∆Cγ∆C 
showed reduced ENaC currents and downregulation by Cl−. In contrast, truncation of the 
amino terminus reduced (β∆N, γ∆N) or even abolished (α∆N) ENaC currents. Individual 
mutations in the PIP2 binding domain (β2N, β4N, γ2N and γ4N) inhibited ENaC currents, 
particularly in βENaC, but did not affect Cl− inhibition. The double mutant β4Nγ4N did not 
produce significant whole cell currents. As further shown, expression of various other 
combinations of double mutants showed compromised inhibition of ENaC by Cl−, when the 
carboxyl terminus of βENaC was truncated. 
 
Expression of αENaC alone generated a small but significant Na+ current, which was not 
downregulated by Cl− (Fig. 7B). Additional mutations in the carboxyl terminus of αENaC did 
not change Cl− sensitivity (data not shown). ENaC currents were reduced in dimeric channels 
formed by αENaC together with βENaC or γENaC, but were all inhibited by Cl−, except of the 
dimeric channel containing β∆C (Fig. 7B). Taken together, the results suggest that (i) αENaC 
does not participate in the control of ENaC by intracellular Cl−, (ii) the COOH terminus of 
βENaC confers Cl− sensitivity and has a central role for the regulation of ENaC by CFTR, and 
(iii) both NH2 termini of βENaC and γENaC containing the PIP2 binding motif determine the 
activity of ENaC, and the amount of ENaC controlled by Cl−. 
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Fig. 7: Summary of double voltage clamp experiments with oocytes co-expressing 
wtENaC or various ENaC mutants in different combinations together with CFTR or 
CLC-0. CFTR was pre-activated with IBMX (1 mM) and forskolin (2 µM). Black bars indicate 
the ratio of the conductance generated by mutant ENaC to that produced by wtENaC at low 
(5 mM) bath Cl− concentration. White bars indicate the ratio for the inhibition of mutant ENaC 
to that of wtENaC by an increase of bath Cl− from 5 to 100 mM. A) All three αβγENaC 
subunits were co-expressed to/from trimeric channels. B) Monomeric channels were formed 
by αENaC only, or dimeric channels were formed by αβENaC or αγENaC. *Indicates 
significant effects of amiloride (black bars) and significant inhibition of ENaC during an 
increase of Cl− from 5 to 100 mM (white bars; paired t-test). #Indicates significant difference 
in the amplitude of amiloride-sensitive currents generated by mutant ENaC when compared 
with wtENaC (black bars) and significantly attenuated inhibition of mutant ENaC by Cl− (white 
bars, unpaired t-test). The number for each series of experiments was n=6−36.  
 
 
Discussion 
 
The present results clearly demonstrate inhibition of amiloride-sensitive Na+ currents by 
activation of CFTR or CLC-0 Cl− channels. In contrast, ENaC currents were not affected by a 
parallel K+ conductance or by a non-selective conductance induced by nystatin. Inhibition of 
ENaC by CFTR has been questioned in two studies and it was suggested that the inhibitory 
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effect of CFTR on ENaC could be attributed to problems arising from high levels of channel 
expression and suboptimal recording conditions, such as a large series resistance and/or 
insufficient feedback voltage gain (165;166). However, several facts argue against the 
possibility of a series resistance error as an explanation for the present and previous results: 
(i) In contrast to Refs. 166 and 165, CFTR and ENaC currents were of a much smaller 
amplitude in the previous reports (33;34;42;86;97;98;109;121;123;142;191). (ii) Inhibition of 
ENaC by CFTR was observed at whole cell currents as low as 1.5 µA (34;108;142;192), 
which is roughly 10-fold below the currents reported in Refs. 166 and 165. (iii) Experiments 
were performed with large dimension, low resistance KCl electrodes, avoiding a significant 
artificial voltage drop along series resistances (34;121;142;191). (iv) Experiments performed 
with different oocyte voltage clamp amplifiers and two bath electrodes with compensation 
circuit confirmed previous results (33;109;123;212). (v) Including the present report, a 
roughly 50% inhibition of ENaC currents by activation of CFTR was found in most of the 
previous studies (34;86;97;109;110;142;190;231). (vi) Co-expression of large K+ 
conductances together with ENaC should exert the same artifact as activation of CFTR Cl− 
currents according to Ref. 165. This, however, was not observed in the present and a 
previous report (110). (vii) Partial permeabilization of oocytes with amphotericin B, which 
induced a large leak conductance did not compromise detection of GAmil (109). (viii) Partial 
permeabilization of oocytes with nystatin in the present study, or co-expression of another 
parallel K+ conductance did not compromise the measurement of GAmil. Taken together, it is 
rather unlikely that the reported inhibition of ENaC by CFTR is a result from compromised 
measurements of whole cell currents in Xenopus oocytes.  
 
It was discussed that in epithelial tissues such as the reabsorptive sweat duct, where both 
CFTR and ENaC reside in the same apical membrane, the absence of CFTR necessarily 
reduces absorption of Na+ because of coupled movement of both Cl− and Na+ (165;166;183). 
Whereas this may accurately describe the situation for a tight epithelium such as the sweat 
duct, where all electrolyte transport occurs transcellularly, the situation is quite different for 
the airways, which is a leaky epithelium unable to maintain larger osmotic gradients (30;147). 
Additional Na+ conductance, as present in the airways of cystic fibrosis patients, will 
necessarily lead to an increase in Na+ and Cl− absorption, with consecutive loss of airway 
surface liquid and reduced mucociliary clearance. This has been convincingly demonstrated 
in a novel transgenic mouse model with airway-specific overexpression of ENaC. In contrast 
to CFTR-transgenic animals, these mice reproduce a lung disease with all typical features of 
a CF lung, including an increased salt absorption and reduced airway surface liquid (140). 
Thus, enhanced electrolyte absorption because of increased Na+ conductance in the airways 
takes place even in the absence of an additional Cl− selective shunt. 
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As outlined above, an inhibitory effect of CFTR on ENaC has been detected under very 
different experimental conditions and accordingly enhanced Na+ absorption has been 
detected in CF tissues, including human airways and intestine (31;32;120;138;139). In 
contrast, CFTR knock-out mice do not demonstrate a CF lung disease (78). In the mouse, 
expression of CFTR takes place in the nasal epithelium, but is essentially irrelevant in 
trachea and more distal airways (186). Mouse airways are obviously dominated by a Ca2+-
activated Cl− conductance and thus lack of CFTR does not affect ion transport in the airways, 
except the nasal epithelium. Consequently, enhanced Na+ absorption is found in CFTR 
knock-out mice only in the nasal epithelium, but not in the remaining airways (79;170). A 
thorough analysis of the CFTR expression in human airways using a new high affinity CFTR 
antibody revealed that CFTR protein is expressed in the apical membrane of ciliated cells 
within the superficial epithelium and in gland ducts, but hardly detectable in the gland acinus 
and alveolar epithelium. This suggests an essential role of CFTR for the regulation of Na+ 
absorption (113). 
 
The present results demonstrate an increase in the intracellular Cl− concentration in ENaC 
expressing oocytes, when a parallel Cl− conductance and a high bath Cl− concentration is 
present. This is not surprising, because a large Cl− shunt allows for electroneutral uptake of 
NaCl into the oocyte. The results show that Cl− or other anions have an inhibitory effect on 
ENaC, when accumulating on the cytosolic side. It should be pointed out that this inhibitory 
effect of Cl− ions on epithelial Na+ channels confirms results from earlier studies on 
mandibular duct cells, which shows an inhibitory effect of Cl− on epithelial Na+ conductance 
(53;54;91). Our results are also in excellent agreement with a previous report showing that 
deletion of the cytoplasmic NH2 terminus of α-, β- and γENaC dramatically reduces GAmil (43). 
The present results confirm that the carboxyl terminus of βENaC is crucial for downregulation 
of ENaC by CFTR (97). We conclude that the inhibitory effect of CFTR on ENaC is at least in 
part Cl− mediated. Evidence is presented that cytosolic domains of ENaC, in a complex and 
not yet fully understood, participate in this regulation, not excluding the possible role of 
partner proteins. Moreover, it is possible that additional partner proteins may form a complex 
together with ENaC and CFTR, possibly in raft-like lipid platforms (84;112). Although 
participation of some anion-sensitive proteins has been excluded recently (91;123), others 
have not yet been examined. In this regard, the recently discussed metabolic coupling of 
ENaC and CFTR via AMP-activated protein kinases would provide a good candidate 
(40;152). 
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Chapter 4 
 
 
Establishment and characterization of a novel polarized MDCK 
epithelial cellular model for CFTR studies 
 
Abstract 
 
F508del is the most common mutation in the cystic fibrosis transmembrane conductance 
regulator (CFTR) gene that is responsible for the genetic disease Cystic Fibrosis (CF). It 
results in a major failure of CFTR to traffic to the apical membrane of epithelial cells, where it 
should function as a chloride (Cl−) channel. Most studies on localization, processing and 
cellular trafficking of wild-type (wt) and F508del-CFTR have been performed in non-epithelial 
cells. Notwithstanding, polarized epithelial cells possess distinctly organized and regulated 
membrane trafficking pathways. We have used Madin-Darby canine kidney (MDCK) type II 
cells (proximal tubular cells, which do not express endogenous CFTR) to generate novel 
epithelial, polarized cellular models stably expressing wt- or F508del-CFTR through 
transduction with recombinant lentiviral vectors. Characterization of these cell lines shows 
that wt-CFTR is correctly processed and apically localized, producing a cAMP-activated Cl− 
conductance. In contrast, F508del-CFTR is mostly detected in its immature form, localized 
intracellularly and producing only residual Cl− conductance. These novel cell lines constitute 
bona fide models and significantly improved resources to investigate the molecular 
mechanisms of polarized membrane traffic of wt- and F508del-CFTR in the same cellular 
background. They are also useful to identify/validate novel therapeutic compounds for CF. 
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Introduction 
 
Cystic fibrosis (CF), a clinically complex disease known as the most common lethal inherited 
disorder among Caucasians, is caused by mutations in the cystic fibrosis transmembrane 
conductance regulator (CFTR) gene, which encodes a membrane protein that functions as a 
cAMP-activated chloride (Cl−) channel. CFTR is expressed in a wide variety of epithelial 
cells, including those lining sweat ducts, small pancreatic ducts, airways surface and 
submucosal gland, intestinal surface and crypts, and kidney tubules (46;56;60). 
 
A high number of different loss-of-function gene variants causes distinct cellular defects on 
the resulting protein. However, one single mutation, the deletion of phenylalanine residue at 
position 508 (F508del) of CFTR, occurs in about 90% of CF patients. It is believed that 
deletion of Phe-508 causes a protein folding defect (45;135;179;237) and the resulting 
abnormal CFTR conformation is recognized as such by the endoplasmic reticulum (ER) 
quality control that targets most of it for degradation via the ubiquitin-proteasome pathway 
(96;226). 
 
A limited amount of cAMP Cl− conductance, however, is detected at the epithelia surface of 
F508del-homozygous patients and mice, suggesting that the ER retention is not absolute in 
native tissues (21;144;220). Consistently, minor expression of F508del-CFTR can be 
detected at the cell surface in recombinant cells, CF primary airway cells, and CF native 
tissues using a large variety of anti-CFTR antibodies (55;99;174;188;236). 
 
Polarized monolayers of human airway epithelial cells are thus the desirable model to study 
CFTR traffic and indeed there is a number of human airway epithelial cell lines from CF 
patients that are able to polarize in culture (for a review see (80)). These immortalized cell 
lines are of significant importance to study CFTR because the scarcity of material provided 
by native tissues and primary cell systems causes major limitations to the feasibility of the 
experiments that can actually be carried out (80). However, they are often difficult to maintain 
in culture and to keep consistent and reproducible transepithelial resistance (Rte) values. 
Moreover, their CFTR expression levels have been observed to decrease with increasing 
number of passages (80). 
 
Therefore, the majority of studies on the traffic and processing of wt- and F508del-CFTR 
have been conducted in heterologous, non-epithelial or non-polarized/epithelial cellular 
systems. Because the efficiency of CFTR processing has also been shown to be widely cell-
type- and polarization-dependent, with endogenous epithelial CFTR maturation patterns 
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differing from those reported in overexpressing systems (16;218), our aim was to generate 
novel epithelial, polarized cellular models stably expressing wt- or F508del-CFTR. 
 
We have thus herein established and characterized two novel cellular models by stably 
transducing MDCK type II cells with wt- or F508del-CFTR recombinant lentivirus. MDCK type 
II cells were the model of choice due to their reported absence of endogenous CFTR protein 
expression and cAMP-stimulated Cl− conductance (159). 
 
These models are characterized here for their CFTR expression at the RNA and protein 
levels as well as regarding the intracellular localization of the respective transgene product 
and also in terms of their transepithelial electric properties. Results presented demonstrate 
that these novel epithelial/polarized cell lines are bona fide models to investigate the 
differences in wt- and F508del-CFTR polarized expression and traffic on the same cellular 
background, being thus relevant tools to elucidate the basic cellular mechanisms of CF 
disease. 
 
Material and Methods 
 
MDCK type II cells 
 
Derived by SH Madin and NB Darby from the kidney tissue of an adult female cocker spaniel, 
MDCK cells were originally produced in September 1958 and ever since have been 
commonly used as a general model to study protein traffic in epithelial cells (153;161;200). 
MDCK cells are easy to maintain, form highly polarized monolayers of epithelial cells when 
grown on filters, with microvilli in the apical surface and with the basolateral membrane 
interdigitating with the filter. Moreover, their membrane trafficking pathways have been 
thoroughly characterized (for a review see (161)). Cultured monolayers of MDCK cells 
display many features of in vivo epithelia and their growth on permeable substrates also 
allows measurement of electrophysiological parameters (158). 
 
However, MDCK cells were previously shown to be heterogeneous in nature, with marked 
differences reported between type I and type II cultures. It is believed that the two MDCK 
strains consist in distinct cell populations derived from the same initial pool of cells, being 
strain I cells derived from the distal collecting duct, while strain II cells are most probably 
derived from the proximal tubule (184). Some authors, however, suggests that MDCK II may 
be of thick ascending limb origin (168). MDCK type II cells used here were obtained from the 
ATCC (Rockville, MD, USA). 
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Viral transduction 
 
MDCK type II cells were transduced to overexpress CFTR (Tranzyme Corporation from 
Birmingham, Alabama, USA). Cells were infected with HIV-based translentiviral recombinant 
vectors containing the human wt- or F508del-CFTR cDNAs, as previously described 
(13;101). Cells were maintained in DMEM/F12 medium supplemented with 10% (v/v) fetal 
bovine serum (FBS) and 1% glutamine (both from Invitrogen, Carlsbad, CA, USA) at 37°C in 
a humidified incubator in 5% (v/v) CO2 and selection was performed with 2 µg/ml of 
blasticidin S (Sigma, St Louis, MI, USA) for MDCK wt-CFTR cells and 4 µg/ml of puromycin 
(Invitrogen) for MDCK F508del-CFTR cells. Following transfection of MDCK II cells (that do 
not express endogenous CFTR) with HIV-based translentiviral vectors, clones were selected 
and characterized for CFTR expression (by reverse transcription polymerase chain reaction, 
RT-PCR and Western blotting, WB), subcellular localization (by immunofluorescence) and for 
transepithelial electric properties (through Ussing chamber measurements). 
 
Cell culture conditions 
 
Cells were grown on 24 mm polyester Transwell filter supports (Corning Costar, Cambridge, 
MA, USA), with an area of 4.7 cm2 and a pore size of 0.4 µm. Rte was measured using an 
EVOMX Epithelial Ohmmeter with a STX2 electrode (WPI, Sarasota, FL, USA). 
 
CFTR transcript analysis by RT-PCR 
 
Total RNA was isolated using the RNeasy extraction kit (Qiagen, Hilden, Germany) 
according to the manufacturer’s instructions. Total RNA concentration was determined by 
measurement of A260 and 1µg was treated with 1 U of RNAse-free DNAse I (Invitrogen) for 
15 min at room temperature to eliminate contamination with genomic DNA. DNAse-treated 
RNA was used for the synthesis of complementary DNA (cDNA). RNA was annealed to 100 
pmol of random hexamers (Invitrogen), the mixture was incubated for 10 min at 60°C and 
then chilled on ice. Following the addition of 5 × first strand buffer (Invitrogen), 0.1M DTT 
(Invitrogen), 25 mM dNTP mix (Amersham Biosciences, Uppsala, Sweden) and 20 U 
RnaseOut (Roche, Basel, Switzerland), contents were incubated for 2 min at 42°C. 
SuperScript II RNaseH-reverse transcriptase (RT) (200 units; Invitrogen) was then added 
and the final mixture was incubated for 60 min at 42°C for reverse transcription. The RT 
enzyme was inactivated by heating at 70°C for 15 min. The PCR amplification of the cDNA 
products was carried out in a reaction that contained 5 µl of cDNA, 10 × PCR buffer, 25 mM 
dNTP mix (Amersham), 10 pmol of each primer and 1 U Taq polymerase (Perkin Elmer, 
Norwalk, CT, USA). Three sets of primers were used for the PCR amplification: 
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− “universal mammalian” CFTR primers amplifying from 5´ of exon 22 to 3´ of exon 23 (~ 200 
bp fragment) (221): forward primer 5´-CTAAGCCATGGCCACAAGCA-3´ (positions 
4168−4187 of human CFTR mRNA, GenBank Accession Number M28668) and reverse 
primer 5´-CATTGCTTCTATCCTGTGTT-3´ (4353−4372), 
 
− human CFTR primers amplifying a fragment spanning exons 8 to 10 (391 bp fragment) 
(180): forward primer 5´-AATGTAACAGCCTTCTGGGAG-3´ (1318−1338 of human CFTR 
mRNA) and reverse primer 5´-GTTGGCATGCTTTGATGACGCTTC-3´ (1685−1708),  
 
− β-actin primers amplifying a fragment spanning exon 8 to 10 (227 bp fragment) (157): 
forward primer 5´-GCACTCTTCCAGCCTTCC-3´ (positions 852−869 of human β-actin 
mRNA, GenBank Accession Number BC014861) and reverse primer 5´-
GCGCTCAGGAGGAGCAAT-3´ (1079−1062). 
 
For the mammalian CFTR and human β-actin set of primers, cDNA samples were heated at 
94°C for 5 min and then subjected to 35 amplification cycles of denaturation at 94°C for 1 
min, primer annealing at 57°C for 1 min, and extension at 72°C for 2 min, followed by a final 
extension at 72°C for 12 min. For the human CFTR set of primers, the only difference was 
the annealing temperature, which was 60°C. DNA fragments were visualized after agarose 
gel electrophoresis by staining with ethidium bromide. The following negative controls were 
included: water instead of RNA and no RT. 
 
Automatic sequencing 
 
PCR products were purified with the JetQuick kit (Genomed, Lohne, Germany) and 
sequencing was performed on a 3100 Genetic Analyser (Applied Biosystems, Norwalk, CA, 
USA), using the ABI PRISM™ Dye Terminator Cycle Sequencing kit (Applied Biosystems) 
according to the manufacturer’s procedure. 
 
Western blotting and treatment with glycosidases 
 
Protein quantification, WB and treatment with glycosidases were performed as previously 
described (63;64). 
 
Antibodies 
 
For immunofluorescence subcellular localization, all antibodies (Abs) were diluted in 0.5% 
(w/v) BSA in PBS and for WB in 5% (w/v) skimmed milk in PBS. The following Abs, 
previously shown to specifically recognize CFTR (154), were used: monoclonal (mAb) 24-1 
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(R&D Systems; Abington, UK) raised against amino acid (aa) residues 1377−1480 (99) 1:20, 
polyclonal (pAb) MPCT-1 (a kind gift from Dr. R. Dormer; University of Wales, Cardiff, UK) 
raised against the C terminus (55) 1:100 and M3A7 mAb (Chemicon, Temecula, CA, USA) 
raised against aa residues 1370−1380 (102) 1:2000. 
 
Other primary Abs were anti-Rab4 pAb (Stressgen, Victoria, BC, Canada), 1:250; anti-
GM130 mAb (BD Transduction, San Jose, CA, USA), 1:250; anti-E-cadherin (BD), 1:100; 
anti-α/β-tubulin mAb (Amersham), 1:100; anti-cytokeratin18/19 mAb (Roche, Basel, 
Switzerland), 1:1500. Secondary Abs were: FITC-conjugated, anti-rabbit IgG (Amersham), 
1:50; FITC-conjugated anti-mouse IgG (Roche), 1:60; TRITC-conjugated, anti-mouse IgG 
(Sigma), 1:600 and HRP-conjugated anti-mouse IgG (Amersham), 1:3000. 
 
Subcellular localization by immunofluorescence 
 
Cells grown on 8-well chamber slides (Nalge Nunc, Roskilde, Denmark) or on Transwell 
filters were incubated for 18 h with 5 mM sodium butyrate, an inhibitor of histone 
deacetylases (HDACs) and thus a transcriptional activator of non-housekeeping genes (160), 
for enhancement of CFTR expression. Slides/filters were rinsed twice with cold PBS and 
fixed in ice-cold methanol for 10 min. After two washes with PBS, cells were permeabilized 
with 0.2% (v/v) Triton X-100 in PBS for 15 min, washed 3 times in PBS, and blocked with 1% 
(w/v) BSA/PBS for 30 min prior to incubation with the primary Ab for 90 min at room 
temperature. Cells were then washed three times with PBS and incubated with the 
secondary Ab for 30 min at room temperature. Slides were mounted with Vectashield (Vector 
Laboratories, Burlingame, CA, USA) containing DAPI (Sigma). Immunofluorescence staining 
was observed and recorded on an Axioskop fluorescence microscope (Zeiss, Jena, 
Germany) equipped with a cooled CCD camera (Photometrics, Tucson, AZ, USA). Images 
were processed with the Power Gene 810/Probe software system (PSI, Chester, UK). 
Confocal images were obtained in a MRC-600 laser confocal imaging system with the 
Comos software package (BioRad, Hercules, CA, USA). 
 
Transepithelial short- and open-circuit measurements 
 
For short-circuit current measurements, filters were mounted in modified Ussing chambers 
(Jim’s Instruments, Iowa City, IA, USA) and bathed on both sides with identical HEPES-
buffered saline solutions that contained (mM) 130 NaCl; 5 sodium pyruvate; 4 KCl; 1 CaCl2; 1 
MgCl2; 5 glucose and 5 HEPES-NaOH (pH 7.4). Bath solutions were gassed with room air. 
Solution temperature was maintained at 37°C. Short-circuit current (Isc) measurements were 
obtained by using an epithelial voltage clamp (VCC-600; Physiologic Instruments, San 
Diego, CA, USA). Forskolin (Fsk) (20 µM) was added to the bathing solution to stimulate 
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cAMP-mediated Cl− secretion. Cl− secretory currents were identified on the basis of activation 
by forskolin and by sensitivity to basolateral glibenclamide (Glib) (200 µm). 
 
For open-circuit measurements MDCK cells were grown for 3−12 days on permeable 
supports (MilliporeMA, Germany) coated with rat-tail collagen (Roche, Germany). The 
resistances of the monolayers were checked every day using a volt-Ω-meter (Millicell-ERS, 
Millipore, Germany) and typically reached values between 600 and 1800 Ωcm2. Apical and 
basolateral surfaces of the epithelium were perfused continuously at a rate of 10 ml/min 
(chamber volume 2 ml). The bath solution contained (mM): 145 NaCl; 0.4 KH2PO4; 1.6 
K2HPO; 5 D-glucose; 1 MgCl2; 5 HEPES and 1.3 Ca-gluconate (pH 7.4). Bath solutions were 
maintained at 37°C. The transepithelial resistance (Rte) was determined by applying short (1 
s) current pulses (I=0.5 µA). 
 
Results 
 
CFTR transcript analysis 
 
Firstly, CFTR expression in the transduced MDCK cells was characterized by RT-PCR 
analysis with two different pairs of CFTR primers (mammalian and human-specific, 
respectively). The “universal mammalian” primers amplified a 200 bp fragment spanning the 
region between exons 22−23 and were selected due to their reported success in amplifying 
CFTR transcripts from seven different mammalian species (221). The human-specific 
primers amplifying a fragment of 391 bp spanning exons 8−10 were previously described 
(180). Samples were also amplified for the housekeeping gene β-actin as a control (157). As 
shown in Fig. 1A, CFTR transcripts were amplified by the two different sets of primers in the 
three cell lines tested: the parental MDCK II (PAR), MDCK wt-CFTR and MDCK F508del-
CFTR, showing that the human-specific primers can also amplify canine CFTR transcripts. 
However, results show that for a similar intensity of the β-actin-specific band, significantly 
lower levels are obtained for the CFTR-specific band in parental cells in comparison to wt- or 
F508del-CFTR transfected cell lines (compare lane 2 to lanes 3 and 4 in Fig. 1A). 
 
Sequencing of these RT-PCR amplification products and nucleotide alignment analysis with 
human CFTR (Fig. 1B), revealed that in both wt- and F508del-CFTR transfected cell lines, 
transcripts correspond to CFTR of human origin (i.e., expressed from the transgene) 
whereas transcripts detected in the parental line correspond to canine CFTR, i.e., resulting 
from endogenous expression. 
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Fig. 1: CFTR transcript analysis in MDCK II cells. A) RT-PCR analysis of CFTR transcripts 
in MDCK II cells. Total RNA was prepared from parental and CFTR-transfected MDCK II 
cells. Samples of 1.0 µg of total RNA were reverse-transcribed to cDNA and PCR-amplified 
with mammalian or human-specific CFTR primers. β-actin-specific primers were used as a 
positive control for the RT-PCR and a reaction with no RNA was the negative control. B) 
Sequence alignment of the RT-PCR products from parental and CFTR-transfected MDCK II 
cells with human CFTR mRNA (GenBank Accession Number M28668), using the BioEdit 
software package (Tom Hall, Ibis Therapeutics, Carlsbad, CA, USA). In red boxes are 
marked the differences between the MDCK parental endogenous CFTR transcript and 
human CFTR. 
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We have submitted the sequences of these canine CFTR transcripts to the EMBL Nucleotide 
Sequence database, as expressed sequence tags (EST) with accession numbers: 
AJ810177, (EST resulting from exons 22/23 amplification, clone CFTR22) and AJ8110178 
(EST from exons 8/10, clone CFTR8). 
 
Expression of CFTR protein by MDCK cells 
 
In order to assess expression of CFTR protein, total protein extracts from parental, wt-CFTR 
and F508del-CFTR MDCK cells were analysed by WB (Fig. 2A). To enhance CFTR 
expression levels, cells were incubated with sodium butyrate, an inhibitor of HDACs and thus 
a transcriptional activator of non-housekeeping genes (160) (see Methods). Results in Fig. 
2A show that CFTR is not detected in MDCK parental cells and is only detected in 
transfected cell lines when incubated with butyrate. To confirm the nature of the bands 
detected, Western blot analysis combined with digestion with two glycosidases, Endo H and 
PNGase F was also performed (Fig. 2B). Results show that in wt-CFTR transfected MDCK 
cells the protein is fully-glycosylated, as demonstrated by the presence of the typical two-
band pattern: the mature, Endo H-resistant and PNGase F-sensitive band C and the 
immature, Endo H- and PNGase F-sensitive band B. In contrast, F508del-CFTR is only 
detected as the immature ER-characteristic form (band B) that is sensitive to both 
glycosidases (63). 
Since expression of membrane proteins is known to depend on the degree of polarization of 
epithelia, we examined here whether expression of CFTR is altered in MDCK II cells under 
highly polarized conditions. MDCK cells were maintained on permeable filter supports for 10 
days to induce polarization, and WB analysis (Fig. 2C) shows that when these cell lines 
polarize, expression levels of wt- and F508del-CFTR are significantly increased in 
comparison to non-polarized cells. 
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Fig. 2: Characterization of CFTR protein expression. A) Western blot of total protein 
extracts from parental (PAR), wt-CFTR and F508del-CFTR MDCK cells. Cells were grown on 
plastic dishes and incubated with 5 mM sodium butyrate for 18 h (but.). Cell lysates were 
prepared (µg of protein indicated) and resolved on a SDS-polyacrylamide gel before 
electrophoretic transfer to nitrocellulose for immunodetection of CFTR, using M3A7 Ab. Wt-
CFTR baby hamster kidney cells (BHK) were used as a positive control. B) Western blot 
analysis combined with digestion with Endo H and PNGase F of total protein extracts from 
wt-CFTR and F508del-CFTR MDCK cells. Cells were grown on plastic dishes and incubated 
with 5 mM sodium butyrate for 18 h to enhance expression. Cell lysates (150 µg) were 
treated with the Endo H and PNGase F glycosidases, as indicated, proteins precipitated and 
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resolved on a SDS-polyacrylamide gel before electrophoretic transfer to nitrocellulose for 
immunodetection of CFTR, using M3A7 Ab. C) Western blot of total protein extracts (250 µg) 
from parental, wt-CFTR and F508del-CFTR cells. Cells were grown on plastic dishes (polariz 
-) or on filters (polariz +) and incubated with 5 mM sodium butyrate for 18 h. Proteins were 
resolved on a SDS-polyacrylamide gel before electrophoretic transfer to nitrocellulose for 
immunodetection of CFTR and calnexin, which was used as an internal control. Wt-CFTR 
baby hamster kidney cells (BHK) were used as a positive control. 
 
 
Subcellular localization of CFTR 
 
In order to evaluate the localization of CFTR in MDCK transfected cells, immunofluorescence 
microscopy was performed with two different anti-CFTR Abs (see Methods), namely: mAb 
24-1 (Fig. 3A−C) and pAb MPCT1 (Fig. 3D−F). Results show that wt-CFTR exhibits 
membrane localization (Fig. 3B and E, compare with Fig. 4B), whereas F508del-CFTR is 
localized intracellularly (Fig. 3C and F), in an ER-like staining pattern (compare with Fig. 4A). 
No specific CFTR labelling was detected in MDCK II parental cells (Fig. 3A and D). 
 
To characterize the localization of CFTR in polarized cells, MDCK wt- and MDCK F508del 
cells were grown on filters, immunostained with 24-1 anti-CFTR mAb and analysed by 
confocal microscopy. Sections on the z plane of the cells, from the apical to the basal 
membrane were acquired. While wt-CFTR localized predominantly in the apical region (Fig. 
3G), F508del-CFTR showed mostly an intracellular, perinuclear distribution (Fig. 3H). These 
results are consistent with those evidencing wt- and F508del-CFTR localization in non-
polarized cells (Fig. 3A−F). 
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Fig. 3: Immunolocalization of CFTR in parental, wt-CFTR and F508del-CFTR MDCK 
cells. Cells were grown in 8-well chamber slides and analysed by immunofluorescence using 
the 24-1 mAb (A−C) or the MPCT1 (D−F) pAb against CFTR. F508del-CFTR (C and F) is 
detected strictly in the cytoplasm, while wt-CFTR (B and E) is located at the plasma 
membrane. No specific CFTR labelling was detected in MDCK II parental cells (A and D). 
Confocal fluorescence micrographs (z axis) of wt-CFTR (G) and F508del-CFTR (H) detected 
in polarized MDCK cells grown on filters and analysed by immunofluorescence using the 
anti-CFTR 24-1 mAb. Bar=20 µm. 
 
 
Immunolocalization of several organelle markers was also performed, showing that non-
polarized MDCK II cells present a diffuse ER staining pattern (Fig. 4A), a perinuclear Golgi 
localization (Fig. 4C) and a well-differentiated cytoskeleton network (panels E and F). E-
cadherin was chosen as a membrane marker (Fig. 4D), while Rab4, a marker for the early 
endosomes, exhibits a localization that seems almost juxtaposed to the membrane (Fig. 4B). 
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Fig. 4: Immunolocalization of several organelle markers in parental MDCK cells. Cells 
were analysed by immunofluorescence using the following Abs: A) anti-calnexin for ER 
staining; B) anti-Rab4 for early endosomes (arrow shows perimembranar localization); C) 
anti-GM130 for Golgi; D) anti-E-cadherin for plasma membrane; E) anti-tubulin for 
microtubules and F) anti-cytokeratin 18/19 for intermediate filaments of epithelial cells. 
Bar=20 µm. 
 
 
CFTR functional analysis 
 
Functional expression of CFTR in the transfected cell lines was assessed through 
transepithelial open- and short-circuit current measurements. Under short-circuit conditions, 
secretory CFTR currents were identified on the basis of activation by forskolin (Fsk, 20 µM) 
and inhibition by glibenclamide (Glib, 200 µM). Fsk-stimulated Cl− secretion was clearly 
detected in wt-CFTR expressing cells (Fig. 5A), while MDCK F508del-CFTR only evidenced 
residual Fsk response when grown at 37°C (Fig. 5B). However, when F508del-CFTR cells 
were incubated at 27°C for 24 h, the Fsk response and inhibition by Glib was increased.  
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Fig. 5: Functional analysis of CFTR in short-circuit measurements. A) Original recording 
of the short-circuit current induced by forskolin (Fsk, 20 µM) and inhibited by glibenclamide 
(Glib, 200 µM) in MDCK wt-CFTR cells. B) A modest and transient increase in Isc was also 
detected upon addition of forskolin to F508del-CFTR MDCK cells, which was enhanced 
following a 24 h-incubation at 27°C (C). Arrows indicate time of addition of forskolin or 
glibenclamide, respectively. 
 
 
Open-circuit conditions (Fig. 6) confirmed these results and showed a large increase in the 
transepithelial conductance (Gte) of wt-CFTR cells upon stimulation with 3-isobutyl-1-
methylxanthine (IBMX) and forskolin (I/F; 100 µM/2 µM) and just a minor increase in 
F508del-CFTR cells. Parental cells did not respond at all (Fig. 6A). Amiloride-sensitive Na+ 
transport was not detected in any of the three cell lines and could not be induced by 
dexamethasone (5 days/0.1 µM) (data not shown). Moreover, we examined Ca2+-activated 
transport by stimulation of luminal purinergic receptors with ATP (A, 100 µM). Large changes 
in transepithelial voltage and an increase in transepithelial conductance upon ATP 
stimulation were detected in early cultures (4 days) of all three cell lines, while Ca2+-activated 
Cl− conductance was progressively lost during continuous culture on permeable supports (12 
days) (Fig. 6B and C). 
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Fig. 6: Functional analysis of CFTR in open-circuit measurements. A) Summary of the 
transepithelial conductances (Gte) activated by IBMX and forskolin (I/F; 100 µM/2 µM) under 
open-circuit conditions in parental (PAR), wt-CFTR (wt) and F508del-CFTR (∆F) cells. B) 
Original recording of the transepithelial voltage (Vte) and changes induced by ATP (A, 100 
µM) in an early (4 days) and a late (12 days) culture of wt-CFTR cells. C) Summary of the 
transepithelial conductances activated by ATP in early and late cultures of wt-CFTR and 
F508del-CFTR cells. *Indicates significant effects of I/F and ATP, respectively (paired t-test). 
n, number of experiments. 
 
 
Discussion 
 
It is well known that protein trafficking is largely dependent on the polarization status of the 
epithelium and yet there are multiple examples of CFTR trafficking studies performed in non-
epithelial/non-polarized cells, mainly due to difficulties in culture of primary cultures and to 
the fact that CFTR expression is progressively lost by immortalized cell cultures (80). 
Examples of studies carried out in non-epithelial/non-polarized cells include descriptions of a 
non-conventional biosynthetic trafficking pathway (11;234); a late quality control mechanism 
operating at early endosomes (195); characterization of ER-to-proteasome sorting in yeast 
cells (69). 
 
The need and importance of appropriate epithelial polarized cellular models to finely 
investigate both the processing mechanisms and the trafficking pathways of wt- and 
F508del-CFTR in the same background, led us to produce the two novel cellular models 
described here. 
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We had first attempted to produce the cell lines stably expressing wt- and F508del-CFTR by 
transfection using cationic liposomes. Expression of CFTR was characterized in such cell 
lines at the level of transcripts and protein, total and at the membrane. However, after 
several reproducible experiments, a rapid decrease in CFTR protein expression occurred in 
those stable lipofectin-transfected MDCK II cell lines (F. Mendes, unpublished results), 
similarly to what is above described for immortalized primary cultures. 
 
Since virally-transduced cell lines are generally described to exhibit very stable transgene 
expression (209) such an approach was also adopted here. We therefore, used an HIV-
based lentivirus to transduce MDCK II cells with wt- and F508del-CFTR as transgenes and 
thus generate the stable expression systems herein described. Characterization of such cell 
lines at CFTR mRNA level evidenced that MDCK II parental cell line solely transduced with 
the lentiviral vector (i.e., with no transgene) already exhibits detectable levels of CFTR 
transcripts through the sensitive RT-PCR analysis employed here. This was unexpected 
since MDCK II cells had been previously reported to lack CFTR expression (159). These 
apparent contradictory results suggest that either the sensitivity of our RT-PCR protocols is 
higher or that the viral transduction somehow activated the endogenous canine CFTR gene. 
Indeed, sequencing of the respective CFTR RT-PCR product from the parental MDCK cells 
confirmed that it is not of human origin. Additionally, we cannot exclude the possibility that 
the MDCK II cells used here for lentiviral transduction differed from those used by the other 
authors. Notwithstanding, since no CFTR protein could be detected in the MDCK parental 
cell line, at least using the anti-CFTR Abs tested here (see below), we still regard this MDCK 
II cellular system as a good parental line for CFTR transduction. 
 
Results from CFTR protein analysis of MDCK wt-CFTR and MDCK F508del-CFTR cell lines 
evidenced that wt-CFTR is detected mostly as the fully-glycosylated form (band C), typical of 
post-ER cellular compartments, being thus correctly processed, whereas F508del-CFTR 
could only be detected as the immature, core-glycosylated protein (band B) that is 
characteristic of the ER. These biochemical results were confirmed by immunofluorescence 
subcellular localization data, which revealed an apical membrane localization for wt-CFTR 
and most F508del-CFTR localized intracellularly in these cellular systems. Additionally, 
expression levels of both wt-CFTR and F508del-CFTR proteins in these MDCK II cells 
detected by WB at steady-state were shown to be increased when cells are polarized. 
 
Comparison of CFTR expression results in the lentiviral transduced MDCK cells with those 
previously obtained for liposome-transfected MDCK cells, evidenced significantly higher 
expression levels of the CFTR transgene in the transduced cells and, most importantly, 
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sustained expression after a relatively high number of passages (F. Mendes, unpublished 
results). 
 
Functional analysis of the transduced MDCK cell lines by transepithelial open- and short-
circuit current measurements clearly identified secretory CFTR currents (IBMX/forskolin-
activated, glibenclamide inhibited) in MDCK wt-CFTR cells, while MDCK F508del-CFTR cells 
only showed residual Cl− currents in response to IBMX/forskolin when grown at 37°C. 
Parental cells did not respond at all. The Cl− currents of MDCK F508del-CFTR cells were, 
however, increased following a 24 h-incubation at 27°C, consistently with the rescuing effect 
of low temperature described for F508del-CFTR in other cellular systems. 
 
There was no evidence for Na+ transport mediated by the epithelial Na+ channel (ENaC) in 
these cell lines, as none of them evidenced amiloride-sensitive luminal currents, nor could 
these be detected following dexamethasone induction. This observation is not surprising 
since MDCK type II cells are derived from the kidney proximal tubule (184) (see Methods). 
As a consequence of the lack of expression of ENaC channels, the transepithelial voltage of 
the epithelium was close to zero mV in the absence of any stimulation However, upon 
stimulation of luminal purinergic receptors with ATP, Ca2+-activated Cl− transport was clearly 
detected in early cultures (4 days) of all three cell lines, which was progressively lost with 
prolonged (12 days) culture of polarized cells. This progressive loss of Ca2+-activated Cl− 
secretion during prolonged cell culture has also been observed for other epithelial cell lines 
such as M1 (collecting duct cells) or 16HBE (bronchial epithelial cells), and appears to reflect 
changes during differentiation (unpublished observations, K Kunzelmann). 
 
MDCK type I cells transfected with wt- and F508del-CFTR have been used previously 
(133;164), but those systems have the disadvantage of expressing endogenous canine wt-
CFTR protein in significant amounts (14;159). To circumvent the caveats of endogenous 
CFTR expression, the 27-kDa green fluorescent protein (GFP) tag was added at the N 
terminus of CFTR (133). However, this tag most plausibly disrupts the interaction of CFTR 
with other proteins that have been shown to be critical for its membrane traffic in epithelial 
cells, namely components of the SNARE machinery (reviewed in (4)).  
 
Recent studies carried out using such MDCK I cells include the characterization of GFP-
tagged F508del-CFTR trafficking to the plasma membrane under low temperature (213) and 
the identification of the C terminus of CFTR as a PDZ interacting apical membrane retention 
motif (213). MDCK II cells expressing FLAG-CFTR were used to show that CFTR is not 
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involved in the regulation of organelle pH nor on protein post-endocytic traffic (76) and that 
cAMP stimulates the apical recruitment of CFTR (87). 
 
We believe that the novel cellular models produced here are more appropriate to investigate 
polarized membrane trafficking pathways of CFTR. Moreover, they allow comparison of such 
pathways between wt- and F508del-CFTR in the same cellular background. These models 
can also be useful to confirm/discard previously described mechanisms shown to occur in 
non-polarized cells regarding biogenesis, degradation, processing and traffic of CFTR 
(reviewed in (4)) and for the development of pharmacological therapies, namely by high-
throughput screening strategies, aimed at identifying new drugs for the treatment of CF. 
 
We conclude that these novel cell lines constitute bona fide models that mimic wt- and 
F508del-CFTR traffic, processing and function occurring in native polarized epithelial 
systems and provide significantly improved resources for cellular studies focused on the 
pathology or treatment of devastating genetic disorder. 
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Chapter 5 
 
 
Regulation of the epithelial Na+ channel by protein kinase CK2 
 
Abstract 
 
CK2 is an ubiquitous, pleiotropic and constitutively active Ser/Thr protein kinase that controls 
protein expression, cell signalling and ion channel activity. Phosphorylation sites for CK2 are 
located in the C terminus of both β- and γ subunits of the epithelial Na+ channel (ENaC). We 
examined the role of CK2 towards the regulation of ENaC endogenous to native murine 
epithelia and in Xenopus oocytes expressing rENaC. In Ussing chamber experiments with 
mouse airways, colon and cultured M1 collecting duct cells, amiloride-sensitive Na+ transport 
was inhibited dose-dependently by the selective CK2 inhibitor 4,5,6,7-tetrabromobenzotria-
zole (TBB). TBB, the structurally unrelated inhibitors heparin and poly E:Y all inhibited ENaC 
current in oocytes. Expression of a trimeric channel that lacks of both CK2 sites 
(αβS631AγT599A) produced a largely attenuated amiloride-sensitive whole cell conductance and 
rendered the mutant channel insensitive to CK2. Immunocytochemistry demonstrated 
translocation of CK2 to the cell membrane upon expression of wtENaC but not 
αβS631AγT599AENaC. Chemiluminescence measurements suggested that phosphorylation by 
CK2 is essential for ENaC activity, but not for membrane expression of the three (αβγ) ENaC 
subunits. Channels lacking the Nedd4-2 binding motif in βENaC (R561X, Y618A) no longer 
required the CK2 site for channel activity, implying an action of CK2 through inhibition of the 
Nedd4-2 pathway. We propose that the C terminus of βENaC is targeted by this essential, 
conserved pleiotropic kinase that directs its constitutive activity towards many cellular protein 
complexes.  
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Introduction 
 
Electrogenic Na+ absorption across the apical membrane of epithelia utilizes an amiloride-
sensitive channel (ENaC) composed of three (αβγ) subunits produced from different genes 
(38). In kidney collecting duct, distal colon, airway, secretory ducts from a variety of organs 
and the absorptive sweat duct, ENaC is regulated by an interaction between the β- and γ 
subunits (at each C terminus) and the ubiquitin ligase Nedd4-2. The WW domains of Nedd4-
2 bind proline-rich PY motifs in each subunit leading to channel ubiquitination, internalization 
and degradation or channel inactivation (50;156). In turn, the Nedd4-2 interaction with ENaC 
is controlled by phosphorylation of either Nedd4-2, or the C termini of both β- and γENaC. 
Accordingly, the aldosterone induced serum- and glucocorticoid-dependent kinase, SGK1, 
phosphorylates Nedd4-2 on serine 444 and 338 and thereby reduces its interaction with the 
channel (50;204). Apart from this, SGK1 also phosphorylates ENaC directly at ser 621 (51). 
Protein kinase A, which is known to activate ENaC in alveolar epithelial cells, sweat duct and 
kidney, was also shown to phosphorylate Nedd4-2 (at ser 221, 246 and 327) and to reduce 
binding to ENaC (203). Thereby PKA prevents inhibition of ENaC due to phosphorylation at 
thr 613 by the extracellular regulated kinases (ERK) (232). Phosphorylation of thr 613 in 
βENaC and thr 623 in γENaC was shown to increase the channel’s affinity towards Nedd4-2, 
and thereby downregulates channel activity (197). 
 
Thus differential phosphorylation of both β- and γ subunits either enhances or reduces the 
affinity of ENaC for destruction by Nedd4-2, thereby controlling ENaC activity. Along this line 
the G protein-coupled receptor kinase 2 (Grk2) was found recently to upregulate the activity 
of ENaC in salivary duct cells (52). Grk2 acts twenty amino acids downstream of ERK on 
S633 in the C terminus of βENaC. It increases the activity of ENaC by rendering the channel 
insensitive to Nedd4-2 (52). Notably, an increased Grk2 activity has been reported to be 
associated with hypertension in humans and in animal models (65). Therefore imbalance in 
ENaC channel regulation by activatory or inhibitory pathways may lead to inappropriate Na+ 
absorption, hypertension or cystic fibrosis-like phenotype (125). 
 
Additional phosphorylation sites for the pleiotropic but essential protein casein kinase 2 
(CK2) are located in the C terminus of the β- and γ subunits of ENaC (198). It has been 
demonstrated that CK2 specifically binds to and phosphorylates the carboxy termini of both 
these ENaC subunits. As found for the CK2 site (S633) in βENaC a pair of CK2 
phosphorylation sites (βS631 and γT599) are located in close proximity to their respective PY 
motifs. CK2 is not easy to study as siRNA approaches invariably impact on multiple 
pathways due to its multiplicity of targets in signal pathways coupled to its essential function 
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for cell survival. Although no contribution of CK2 to regulation of ENaC followed single site 
mutation of putative CK2 targets in a previous study (198), we nevertheless investigated a 
role for CK2 towards ENaC function in native epithelia from airway and colon as well as 
Xenopus oocytes expressing rat ENaC. We found that constitutive CK2 phosphorylation 
maintains not only ENaC activity but also controls membrane subunit expression.  
 
Material and Methods 
 
Ussing chamber experiments 
 
Tracheas and distal colon were removed from mice euthanased by ethically approved 
institutional procedures (C57BL/6, Charles Rivers, Germany). Tissues were put immediately 
into ice cold buffer solution of the following composition (mmol/l): NaCl 145, KCI 3.8, D-
glucose 5, MgCI2 1, HEPES 5, Ca-gluconate 1.3. After stripping the colonic mucosa and 
opening tracheas by a longitudinal cut, the tissues were mounted into a micro-Ussing 
chamber with a circular aperture of 0.95 mm2. Mouse M1 collecting duct cells (kindly 
provided by C. Korbmacher, Physiologisches Institut, Universität Erlangen, Germany) were 
grown to confluence on permeable supports and mounted into the Ussing chamber (9). 
Luminal and basolateral sides of the epithelium were perfused continuously at a rate of 5 
ml/min. The bath solution containing (mmol/l) NaCl 145, KH2PO4 0.4, K2HPO4 1.6, D-glucose 
5, MgCI2 1, HEPES 5, and Ca-gluconate 1.3, was heated to 37°C, and pH was adjusted to 
7.4. Experiments were carried out under open-circuit conditions. Values for transepithelial 
voltages (Vte) were referred to the serosal side of the epithelium. Transepithelial resistance 
(Rte) was determined by applying short (1 s) current pulses (∆l=0.5 µA) and after subtracting 
the resistance of the empty chamber, using Ohm's law (Rte=∆Vte/∆I). Transepithelial 
resistances were 63 ± 3.8 Ωcm2; n=12 (trachea), 31 ± 2.1 Ωcm2; n=13 (colon) and 669 ± 45 
Ωcm2; n=38 (M1). 
 
cRNAs for ENaC subunits and CFTR 
 
cDNAs encoding rat (FLAG-tagged or non-tagged) αβγENaC (kindly provided by Prof. Dr. B. 
Rossier, Pharmacological Institute of Lausanne, Switzerland (67)) and the Cl− channel CFTR 
were linearized in pBluescript with Notl or Mlul, and in vitro transcribed using T7, T3 or SP6 
promotor and polymerase (Promega, USA). Isolation and microinjection of oocytes have 
been described in details elsewhere (9). The ENaC mutants βS631A, γT599A, βR561X, βY618A, and 
βS633A were generated by PCR and correct sequences were verified by sequencing. 
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Double electrode voltage clamp 
 
Oocytes were injected with cRNA (10 ng, 47 nl double-distilled water). Water injected 
oocytes served as controls. 2−4 days after injection, oocytes were impaled with two 
electrodes (Clark instruments), which had a resistance of <1 MΩ when filled with 2.7 mol/l 
KCI. Using two bath electrodes and a virtual-ground headstage, the voltage drop across 
Rserial was effectively zero. Membrane currents were measured by voltage clamping (Warner 
oocyte clamp amplifier OC725C) in intervals from –90 to +30 mV, in steps of 10 mV, each 1 
s. The bath was continuously perfused at a rate of 5 ml/min. All experiments were conducted 
at room temperature (22°C). 
 
Chemiluminescence measurements 
 
Oocytes were fixed for 60 min at room temperature with 3% paraformaldehyde (in TBS, pH 
8.0) and washed with Tris buffered saline (TBS; (mM) 50 Tris, 138 NaCl, 2.7 KCl, pH 8.0) at 
room temperature. Then oocytes were incubated for 60 min in TBS with 1% bovine serum 
albumin (BSA), another 60 min with 1 µg/ml mouse monoclonal anti-FLAG M2 antibody in 
1% BSA/TBS at 4°C (Sigma-Aldrich, Taufkirchen, Germany), washed at 4°C with 1% 
BSA/TBS and incubated with sheep anti-mouse IgG peroxidase-linked whole antibody 
(Amersham Biosciences, Freiburg, Germany) diluted 1:20000 in 1% BSA/TBS for 40 min at 
4°C. Afterwards oocytes were washed for 60 min at 4°C in 1% BSA/TBS and finally in TBS 
(60 min, 4°C). Oocytes were placed separately in 50 µl ECL Plus Western Blotting Detection 
Reagents (Amersham). After incubation for 5 min at RT, chemiluminescence was measured 
in a BioOrbit 1250 Luminometer (Turku, Finland) and an integration period of 1 s was 
allowed. 
 
Oocyte staining 
 
Oocytes were incubated for 60 min in ND96, fixed for 60 min with 3% paraformaldehyde (in 
TBS, pH 8.0) and washed in TBS. After embedding in optimum cutting temperature 
compound (Sakura Finetek Europe, Zoeterwoude, NL), oocytes were cut to 20 µm slices with 
a cryostat (Leica CM3050 S, Wetzlar, Germany). Sections were put in either TBS or 
phosphate buffered saline (PBS; (mM) 137 NaCl, 1.8 KH2PO4, 10.3 Na2HPO4, pH 7.4), 
incubated for 5 min in 0.1% SDS in PBS and washed 2 times with either TBS or PBS. 
Sections were incubated for 60 min in TBS or PBS (5% bovine serum albumin) and for 60 
min at 37°C with the anti-FLAG M2 antibody diluted 1:50 in 2% BSA/TBS or a goat polyclonal 
casein kinase IIα antibody (Santa Cruz Biotechnology, Heidelberg, Germany) diluted 1:25 in 
2% BSA/PBS. Afterwards sections were washed twice in PBS and incubated for 1 h with 
secondary antibodies (donkey anti-mouse IgG-Alexa Fluor 488 conjugated and donkey anti-
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goat IgG-Alexa Fluor 546 conjugated; Molecular Probes, Eugene, OR) at a dilution of 1:1000 
in 2% BSA/PBS. Sections were washed 2 times with PBS for 5 min and covered with 
DakoCytomation fluorescent mounting medium (DakoCytomation, Inc., Carpinteria, CA). 
Images were obtained using a Zeiss Axiovert 200M microscope with a × 63 objective (Carl 
Zeiss, Inc., Jena, Germany). 
 
Materials and statistical analysis 
 
All compounds used were of highest available grade of purity. Amiloride, 2-dimethylamino-
4,5,6,7-tetrabromo-1H-benzimidazole (DMAT), forskolin, IBMX=3-isobutyl-1-methylxanthine, 
heparin, okadaic acid, poly E:Y peptide and poly K were from Sigma. 4,5,6,7-
tetrabromobenzotriazole (TBB) was a generous gift from Prof. L. Pinna (Department of 
Biological Chemistry, University of Padua, Italy). Student’s t-test was used for statistical 
analysis. A P value of <0.05 was regarded as significant. 
 
Results 
 
CK2 phosphorylation sites in βENaC and γENaC are necessary for ENaC activity 
 
We examined the contribution of CK2 to regulation of epithelial Na+ channels in native 
epithelia from mouse trachea and colon. In Ussing chamber experiments we explored CK2-
selective concentrations of the specific inhibitor TBB (4,5,6,7-tetrabromobenzotriazole), 
which was shown to have no effect on over 30 other kinases. TBB selectivity depends on its 
ability to bind an unusual hydrophobic ATP binding site that differs from the equivalent in 
conventional kinases. Electrogenic Na+ transport in mouse trachea was assessed by 
inhibition of ENaC with amiloride (10 µM) (Fig. 1A). TBB (10 µM) reduced the transepithelial 
voltage Vte and attenuated amiloride-sensitive short-circuit currents (Isc-amil) in a dose-
dependent manner (Fig. 1A and B). Similarly, TBB blocked amiloride-sensitive Na+ transport 
in mouse distal colon (Fig. 1C and D). This effect could be reproduced in cultured mouse M1 
collecting duct cells, grown on permeable supports (Fig. 1E and F). The combined results 
suggested that endogenous epithelial Na+ channels expressed in epithelial tissues are 
maintained in an active state by constitutively active CK2.  
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Fig. 1: CK2 activates ENaC in epithelia. Original Ussing chamber recordings of the 
transepithelial voltages Vte detected in mouse trachea (A), mouse colon (C) and M1 cells (E). 
Effects of amiloride (A, 10 µM) and the CK2 inhibitor TBB (10 µM). Concentration-
dependence of the effects of TBB on amiloride-sensitive transport in trachea (B), colon (D), 
and M1 cells (F). *Indicates significant effects of TBB (paired t-tests). Number of experiments 
9−13 for each series. 
 
 
To further confirm regulation of epithelial Na+ channels by CK2, the three (αβγ) ENaC 
subunits were expressed in Xenopus oocytes and examined in double electrode voltage 
clamp experiments. As shown in the original recording in Fig. 2A, expression of the three 
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ENaC subunits produced a large current, which was inhibited by amiloride (A, 10 µM). CK2 
structure is virtually identical in oocytes compared to mammals and TBB (10 µM) significantly 
reduced amiloride-sensitive whole cell currents and conductance (Gamil), respectively (Fig. 2A 
and B). Another compound, 2-dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole (DMAT), 
has recently been shown to inhibit CK2 with higher inhibitory potency but it has limited 
efficacy in vivo due to rapid metabolism (LA Pinna, personal communication). At 2 µM, we 
did not observe inhibition of ENaC currents by DMAT in Xenopus oocytes, however, 5 µM 
reduced amiloride-sensitive ENaC conductance significantly from 31.9 ± 6.8 to 25.7 ± 4.1 µS 
(n=5). Regulation of ENaC by CK2 was further validated using the structurally-unrelated 
peptide inhibitor of CK2, poly E:Y and conversely, by activating CK2 with polylysine (poly K) 
(149;216). The peptides were injected into oocytes at final concentrations between 10 and 
100 µM, and amiloride-sensitive Na+ conductances were compared before and 1−5 h after 
injection. During these few hours, ENaC conductance further increased almost doubling in 
water injected controls (Fig. 2C), However, this time-enhanced Na+ conductance was 
nevertheless inhibited by poly E:Y and was further activated through stimulation of CK2 by 
poly K (Fig. 2C). CK2 is known to associate with protein phosphatase 2A (PP2A). To confirm 
phosphorylation-dependent activation of ENaC, ooctyes were exposed to a PP2A-specific 
concentration of okadaic acid (10 nM), which further increased amiloride-sensitive Na+ 
transport (Fig. 2D and E). Thus ENaC appears to be activated by constitutively active CK2 
with counter regulation by PP2A-like inhibition. As a further check for CK2 function, injection 
of the non-specific CK2 inhibitor heparin (10 µM) also reduced Na+ conductance in Xenopus 
oocytes (Fig. 4).  
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Fig. 2: CK2 activates ENaC in Xenopus oocytes. A) Current recording from a Xenopus 
oocyte expressing αβγENaC and effects of amiloride (10 µM) and TBB (10 µM). B) Summary 
of the effects of amiloride and TBB on whole cell conductance in ENaC expressing oocytes. 
C) Summary of the change of amiloride-sensitive conductance (Gamil) after injection of water, 
the CK2 inhibitor poly E:Y (50 µM) and CK2 activator poly K (50 µM), respectively. D) Current 
recording of an ENaC expressing oocyte and the effects of amiloride (A, 10 µM) and okadaic 
acid (100 nM). E) Summary of the effect of okadaic acid on the amiloride-sensitive whole cell 
conductance measured in oocytes. *Indicates significant effects (paired t-test). #Indicates 
significant difference for the effects of amiloride before and after incubation with TBB (paired 
t-test). 6−25 experiments for each series. 
 
 
Removal of CK2 sites inhibits amiloride-sensitive Na+ conductance and renders ENaC 
insensitive towards TBB 
 
Similar to endogenous Na+ currents present in epithelial tissues (Fig. 1), ENaC expressed 
exogenously in Xenopus oocytes was inhibited by TBB in a dose-dependent manner (Fig. 3A 
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and C). ENaC contains two phosphorylation sites for CK2, in βENaC (serine 631) and γENaC 
(threonine 599). Changing both CK2 sites to alanines (αβS631AγT599A), virtually eliminated Na+ 
conductance and rendered residual conductance of the doubly mutated channel insensitive 
to TBB (Fig. 3B and D). Trimeric Na+ channels carrying only one mutation in either βENaC or 
γENaC (αβS631Aγ, αβγT599A), produced more measurable but still significantly attenuated Na+ 
conductances when compared to wtENaC (Fig. 3E). Moreover, the remaining amiloride-
sensitive Na+ conductances formed by dimeric αβENaC and αγENaC channels were further 
reduced by βS631A and γT599A, respectively (Fig. 3F). Taken together, these results 
demonstrate that phosphorylation of βS631 and γT599 is essential for an active ENaC. 
 
 
 
Fig. 3: Elimination of CK2 sites inhibits ENaC. A) Current recording from a Xenopus 
oocyte expressing αβγENaC and effects of amiloride (10 µM) and TBB (10 µM). B) Current 
recording from a Xenopus oocyte expressing αβS631AγT599AENaC and effects of amiloride (10 
µM) and TBB (10 µM). C and D) Summaries of the effects of amiloride and TBB on Gamil 
generated by αβγENaC and αβS631AγT599AENaC. E) Comparison of Gamil produced by wt (αβγ)-
, single mutants (αβS631Aγ, αβγT599A)- and a double mutant (αβS631AγT599A) ENaC. F) 
Summaries of Gamil produced by dimeric wt (αβ, αγ)- and mutant (αβS631A, αγT599A) ENaC 
channels. *,#Indicate significant difference (paired t-test). 13−25 experiments for each series. 
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CK2 controls ENaC activity and membrane expression of αENaC 
 
In order to examine whether CK2 phosphorylation controls membrane expression of ENaC, 
Flag-tagged αENaC was co-expressed with non-flagged βγENaC in Xenopus oocytes. 
Appearance of αFlagENaC in the cell membrane was monitored by chemiluminescence, 
during an observation period of 40−48 h (cf Methods). In parallel, amiloride-sensitive Na+ 
conductance was assessed at corresponding intervals. When αFlagβγENaC was allowed to 
express in ND97 control buffer, Gamil and membrane expression continuously increased (Fig. 
4A and B). In contrast, when oocytes were kept in 10 µM TBB containing buffer, amiloride-
sensitive Na+ conductance was completely abolished and membrane expression was 
significantly reduced. Moreover, co-injection of αβγENaC-cRNAs together with the CK2 
inhibitors heparin (final concentration 10 µM) or the peptide inhibitor poly E:Y (final 
concentration 50 µM) also inhibited Na+ conductance along with membrane expression of 
αENaC (Fig. 4C−F). Finally M1 cells were grown on permeable supports, in the absence or 
presence of 10 µM TBB. As observed in oocytes, TBB reduced amiloride-sensitive transport 
from 2.05 ± 0.35 µA/cm2 (n=19) to 1.52 ± 0.25 µA/cm2 (n=16). Thus CK2 phosphorylation 
differentially controls membrane expression of αENaC and ENaC activity. The inhibitory 
effect of conductance (3−5-fold) was significantly greater than on the attenuated expression 
(typically 2-fold). 
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Fig. 4: CK2 controls maturation of ENaC in Xenopus oocytes. Time course for the 
expression of Gamil (A, C, E) and membrane expression of αFlagENaC (B, D, F). Ooctyes were 
kept in ND97 or in ND97 containing TBB (10 µM), or were injected with heparin (10 µM), poly 
E:Y (50 µM) or equal amounts (30 nl) of water. *Indicates significant difference when 
compared to ND97 or water (unpaired t-tests). 6−13 experiments for each series. 
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CK2 is essential for ENaC activity but not for membrane expression of αENaC 
 
The contribution of both CK2 phosphorylation sites in βENaC and γENaC, to membrane 
expression of αENaC was further examined by expressing single mutants (αFlagβS631AγENaC 
or αFlagβγT599AENaC) or the double mutant (αFlagβS631AγT599AENaC). For the sake of simplicity, 
we only show (relative to wild-type) the data for membrane expression and ENaC 
conductance reached after 40 h of expression. Importantly, single mutations in βENaC or 
γENaC largely reduced the Na+ conductance but did not affect membrane expression. 
Notably, elimination of both CK2 sites in βENaC and γENaC also showed no effects on 
membrane expression of αENaC, but nevertheless eliminated the inhibitory effects of TBB 
(Fig. 5 upper panel). Amiloride-sensitive Na+ conductances were strongly reduced for the 
double mutant (Fig. 5 lower panel). These data suggest that single site mutation and double 
site mutation create different effects on ENaC such that TBB significantly reduces αENaC 
expression only when one or other CK2 site is intact. The reason why expression of αENaC 
is unaffected by double mutation is unclear at present. 
 
Since nearby located Grk2 phosphorylation site S633 was reported to control Nedd4-2 
binding to ENaC (52), we explored whether similar may hold true for CK2. To that end, we 
compared whole cell conductances of several mutants compared to wtENaC. A mutation in 
the Nedd4-2 binding site (βY618A) increased whole cell conductance relative to the wild-type 
and eliminated the inhibitory effect of S631A on ENaC conductance (Fig. 5B). This strongly 
suggests that CK2 phosphorylation at S631 antagonizes the inhibitory action of Nedd4-2 in 
ENaC (197) (Fig. 8). Similarly, when we expressed the truncated αβR561XγENaC channel we 
found that amiloride-sensitive whole cell conductance was largely increased (64.5 ± 5.9 µS; 
n=14) when compared to αβγENaC, and was now unaffected by 10 µM TBB (64.1 ± 6.1 µS). 
Interestingly, mutating the Grk2 site also reduced ENaC conductance, however, eliminating 
both CK2 and Grk2 sites in βENaC produced a channel with similar activity than wtENaC 
(Fig. 5B). This suggests that the closely located phosphorylation sites of CK2 and Grk2 
(S631, S633) influence each other. 
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Fig. 5: CK2 is essential for ENaC activity and antagonizes inhibitory effect of Nedd4-2 
on ENaC. A) Summary of αENaC membrane expression and Gamil after 40 h. TBB inhibited 
membrane expression of single mutants (αβS631Aγ, αβγT599A) but not that of the double mutant 
(αβS631AγT599A). Gamil was largely reduced for all mutants and Gamil produced by the double 
mutant was no longer inhibited by TBB. Dashed lines indicate membrane expression and 
Gamil of wtENaC. B) Whole cell conductances relative to wtENaC. A mutation in the PY motif 
(Y618A) increased Na+ conductance and S631A no longer inhibited ENaC conductance. The 
Grk2 mutant S633A inhibited ENaC, but not as a double mutant S631A/S633A. *Indicates 
significant effects of TBB (paired t-tests). 9−24 experiments for each series. 
 
 
CK2 controls expression of βENaC and γENaC 
 
The activity of epithelial Na+ channels largely depends on co-expression of both β- and γ 
subunits. Membrane expression of βENaC and γENaC was monitored by injecting 
αβFlagγENaC or αβγFlagENaC, respectively, and Na+ conductances were measured in parallel. 
Na+ conductances generated by either αβFlagγENaC or αβγFlagENaC, respectively, were 
almost completely abolished when oocytes were exposed to 10 µM TBB, while membrane 
expression of βFlag and γFlag were reduced by only around 50% (Fig. 6A). This indicates 
regulation of membrane expression of βENaC and γENaC, of similar magnitude to that of 
αENaC. We further examined whether βFlag and γFlag behave in a similar fashion in the 
absence of αENaC. Dimeric channels formed by βFlagγENaC or βγFlagENaC produced small 
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but detectable amiloride-sensitive whole cell conductances (0.74 ± 0.2 µS; n=8 and 0.2 ± 0.1 
µS; n=7, respectively). Notably, expression of βFlagENaC and γFlagENaC was not significantly 
reduced in the absence of αENaC and was not inhibited by TBB although both CK2 sites 
were present (data not shown). The results again suggest that CK2 sites control ENaC 
activity to a much greater degree than membrane expression. 
 
In order to further assess the impact of CK2 phosphorylation on membrane expression of 
βENaC and γENaC in trimeric (αβFlagγENaC and αβγFlagENaC) channels, we expressed single 
mutants (αβS631A-FlagγENaC or αβγT599A-FlagENaC) or double mutants (αβS631A-FlagγT599AENaC or 
αβS631AγT599A-FlagENaC) in the absence or presence of 10 µM TBB. For all mutant 
combinations, Na+ conductances were largely reduced and residual conductances generated 
by the double mutants were insensitive to TBB (Fig. 6B and C). In contrast membrane 
expression of βENaC and γENaC was not affected by any of the mutations and expression of 
the double mutants (αβS631A-FlagγT599AENaC; αβS631AγT599A-FlagENaC) was no longer inhibited by 
TBB (Fig. 6B and C). These data suggest that if CK2 sites are present in βENaC and γENaC, 
they need to be phosphorylated to allow proper membrane expression of all three subunits. 
However, while CK2 phosphorylation is essential for channel activity, it does not seem to be 
crucial for membrane expression of either α-, β- or γENaC. 
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Fig. 6: CK2 is not essential for membrane expression of βENaC and γENaC. Summary 
of βENaC and γENaC expression and Gamil after 40 h. A) Inhibition of membrane expression 
of βENaC and γENaC and Gamil by 10 µM TBB. B and C) TBB inhibited membrane 
expression of βFlagENaC and γFlagENaC in single mutants (αβS631Aγ, αβγT599A), but not in 
double mutants (αβS631AγT599A). Gamil was largely reduced for all mutants, and Gamil produced 
by the double mutants was no longer inhibited by TBB. Dashed lines indicate membrane 
expression and Gamil of wtENaC. *Indicates significant effects of TBB (paired t-tests). 6−12 
experiments for each series. 
 
 
ENaC translocates CK2 to the cell membrane 
 
It has been reported that CK2 binds specifically to ENaC (198). This suggests that CK2 may 
be translocated by ENaC to the cell membrane as found CFTR (216). Oocytes expressing 
ENaC and non-injected control oocytes were immunolabeled, after embedding and cutting 
into 20 µm sections. Using an anti-Flag antibody, αENaC could be visualized in membranes 
of Xenopus oocytes expressing αFlagβγENaC (Fig. 7A). Moreover, upon expression of 
αβFlagγENaC or αβγFlagENaC, β- and γ subunits could be immunolabeled in the oocyte 
membrane (Fig. 7B, left panel). Expression of the three subunits was similar in 
αβS631AγT599AENaC injected oocytes (Fig. 7B, right panel). However, while CK2 was detected 
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in membranes of oocytes expressing wtENaC, no membrane staining of CK2 was detectable 
in αβS631AγT599AENaC injected oocytes (Fig. 7B, lower panel). These results suggest that CK2 
may be translocated to oocyte membranes by binding to ENaC β- and γ subunits. 
 
 
 
Fig. 7: wtENaC translocates CK2 to the cell membrane. A) DIC image of the oocyte 
membrane (left panels) and immunostaining of αFlagENaC in an ENaC expressing (right 
upper panel) and a non-injected (right lower panel) oocyte. B) Immunostaining of the three 
ENaC subunits (green) and CK2 (red) in wtENaC (left panel) and αβS631AγT599AENaC (right 
panel) expressing oocytes. Bars indicate 10 µm. Experiments were performed at least in 
triplicates. 
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Fig. 8: Model for CK2 action on ENaC. Binding of the ubiquitin ligase Nedd4-2 leads to 
ubiquitination of ENaC and subsequent degradation of the channel and/or channel 
inactivation. Phosphorylation of ENaC at ser 633 reduces affinity of ENaC for Nedd4-2, 
thereby maintaining membrane localization and activity of ENaC. 
 
 
Discussion 
 
CK2 regulates ion channels 
 
CK2 is an essential, constitutively regulated multifunctional protein kinase, whose functions 
are not fully understood (204). CK2 is thought to insert into protein complexes bringing its 
constitutive activity to many signalling complexes (p53, ion channels, actin capping at 
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membranes, lipid flippases etc). In this respect, it might also be relevant that CK2 controls 
trafficking and sorting of trans-Golgi proteins (albeit via a specific isoform). The constitutive 
activity of CK2 also affects a number of membrane channels and pumps. These include 
polycystin-2 (PC-2), a divalent cation-selective channel where CK2 maintains the Ca2+ 
sensitivity (36). Ca2+ sensitivity of PC-2 was significantly reduced by CK2 site mutation 
(S812A), whereas PC-2 expression was unaffected and we find that ENaC behaves in a 
related manner. However, our observed differential effect between channel function and 
expressions is not universal. For example, CK2-mediated phosphorylation of three critical 
serine residues within nephrocystin is essential for co-localization of nephrocystin with the 
sorting proteins PACS-1 at the base of cilia, and phosphorylation of CK2 sites within PC-2 
were reported to be important for proper ciliary localization of the TRPP channels (88;189). 
Inhibition of CK2 was shown to eliminate interaction of PACS-1 and nephrocystin and to 
induce defective nephrocystin targeting. Thus, CK2 phosphorylation may be relevant to the 
common autosomal form of polycystic kidney disease. 
 
Other ion channels are also described to be regulated by CK2. Thus CK2 regulates the 
current amplitude of voltage-dependent Ca2+ channels (106), as well as Ca2+-dependent 
gating of small conductance Ca2+-activated K+ channels (22). SK channels are organized in 
multiprotein complexes together with CK2 and the protein phosphatase 2A, located in the 
postsynaptic pole of cochlear outer hair cells. Furthermore, CK2 has recently been found to 
regulate CFTR, the chloride channel that is defective in cystic fibrosis. As in this study, CK2 
becomes membrane associated with CFTR. Once again both CK2 and PP2A co-localize with 
different domains of CFTR (149;216). Importantly, CK2 binding is disease relevant. It was 
shown that mutation of the CK2 target at S511 in the first nucleotide binding domain disrupts 
both CFTR channel gating and binding of CK2. TBB inhibited CFTR activity in mammalian 
cells and Xenopus oocytes. Notably, the interaction of CK2 with NBD1 of CFTR was 
abolished by the most common CFTR mutation, F508del. Loss of CK2 binding rendered 
F508del-CFTR insensitive to TBB and CK2 was no longer expressed in the cell membrane 
(216). Once again, CFTR expression determines the cellular localization of CK2, which could 
have effects on other membrane conductances as well such as amiloride-sensitive Na+ 
absorption. It is interesting to note that CK2 is not stimulatory for the function of all proteins 
studied to date. CK2 is inhibitory towards another ABC family member ABCA1 thus 
constitutively suppressing the lipid ‘flippase’ activity of this CFTR related protein. 
 
C terminus of βENaC - a target for kinase regulation of ENaC 
 
Phosphorylation-dependent regulation of ENaC is demonstrated in the present study by 
heparin, a non-specific inhibitor of CK2 directed against acidic motifs, the peptide inhibitor of 
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CK2, poly E:Y and the specific CK2 inhibitors TBB and DMAT. Inhibition of protein 
phosphatases with okadaic acid further increased Na+ conductance, indicating the 
importance of basal CK2-dependent phosphorylation for ENaC regulation (15) and 
elimination of CK2 phosphorylation sites abrogated Na+ conductance in Xenopus oocytes. 
Thus ENaC is compellingly regulated by CK2 in Xenopus oocytes and epithelial tissues 
examined here. Yet in a previous report such a regulation could not be detected in salivary 
duct cells (52). Instead, activation of ENaC by the G protein-coupled receptor kinase 2 (Grk2) 
was found. Due to phosphorylation of S633 by Grk2 in the C terminus of βENaC, the affinity 
of Nedd4-2 binding to ENaC is apparently reduced, thus enhancing ENaC currents. 
According to the present data (Fig. 5B), a similar scenario may hold true for CK2-dependent 
regulation of ENaC. We note that both phosphorylation sites for Grk2 and CK2 are located in 
close proximity to one other. We speculate that since CK2 classically engages in hierarchical 
phosphorylation with other kinases, depending on the cell type and expression levels of the 
kinases involved, phosphorylation through either Grk2 or CK2 could control ENaC activity 
and membrane expression. Moreover, phosphorylation by CK2 is likely to affect regulation by 
Grk2 and vice versa (Fig. 5B). Further experiments will be needed to unravel this complex 
regulatory network and should focus on inhibitory phosphorylation by ERK and its 
counteraction by activation through PKA, Grk2 and CK2, with Nedd4-2 as the central control 
switch (7;52;197;232). 
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Summary 
 
The epithelial Na+ channel (ENaC) is located in the apical membrane of salt (re-) absorbing 
epithelia in kidney, colon, airways and glandular excretory ducts. A variety of mechanisms for 
the regulation of ENaC have been described, which may indicate the necessity for a tight 
control of ENaC and Na+ absorption in the human body. 
Essential tasks of ENaC comprise: 
i) control of volume and electrolyte composition of extracellular fluids 
ii) regulation of blood pressure 
iii) control of Na+ reabsorption 
 
In the present thesis particular attention is given to the regulation of ENaC by 
i) purinergic receptors 
ii) CFTR and changes in the intracellular Cl− concentration 
iii) protein kinase CK2 
 
Using electrophysiological and molecular biological methods it is demonstrated that both 
stimulation of purinergic receptors and activation of CFTR and other Cl− channels lead to 
inhibition of epithelial Na+ channels, resulting in reduced Na+ absorption. Additional 
experiments showed that both mechanisms are additive. Activation of purinergic receptors is 
the starting point for a signalling cascade, leading to inhibition of ENaC via hydrolysis of the 
phospholipid PIP2. The Na+ channel is also inhibited by stimulation of CFTR- or other Cl− 
channels, which change the intracellular Cl− concentration upon activation in co-expression 
experiments. A correlation was found between the degree of ENaC inhibition and the 
increase in intracellular Cl− concentration. A similar correlation was found for the inhibition of 
ENaC by stimulation of purinergic receptors. While binding of ENaC to PIP2 keeps the 
channel in an active state, interference of ENaC with intracellular Cl− seems inhibitory on 
ENaC function. 
 
To carry out CFTR studies under conditions like in native tissue, two new cell lines were 
created from MDCK type II cells (polarized canine kidney epithelial cells), which stably 
express wt-CFTR or its mutant counterpart F508del-CFTR. The cell lines have been proven 
to grow as tight monolayers and are therefore suitable for Ussing chamber experiments. 
Subsequent co-expression of ENaC will allow to study the interaction between CFTR and 
ENaC in a polarized epithelium. 
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CK2 is a constitutively active protein kinase that influences the activity of the channel through 
its binding and phosphorylation of both β- and γ subunits of ENaC. Lack of these 
phosphorylation sites or dephosphorylation of one of these sites results in a significant 
attenuation of the activity of the epithelial Na+ channel. These and other experiments suggest 
that phosphorylation of both β- and γENaC by CK2 prevents binding of the ubiquitin ligase 
Nedd4-2 to ENaC. Lack of binding of Nedd4-2 to ENaC may result in both reduced 
endocytosis and accumulation of ENaC in the cell membrane as well as increase in ENaC 
activity. 
 
A better understanding of the mechanisms that are involved in the regulation of the epithelial 
Na+ channel may contribute to the identification of new therapeutic targets. In this way, 
diseases that are connected with a dysfunction of ENaC could be treated more effective, 
which may improve quality of life and prognosis of patients. 
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Zusammenfassung 
 
Der epitheliale Na+-Kanal, kurz ENaC, wird in der apikalen Membran von Kochsalz-(re-) 
absorbierenden Epithelien in Niere, Kolon, Luftwegen und exkretorischen Drüsen exprimiert. 
Für die Regulation von ENaC sind eine Vielzahl von Mechanismen beschrieben, was die 
Notwendigkeit einer strengen Kontrolle des ENaC und der Na+-Absorption im menschlichen 
Körper erkennen lassen dürfte. 
Die wesentlichen Aufgaben von ENaC bestehen u.a. aus: 
i) Kontrolle des Volumens und der Elektrolyt-Zusammensetzung des Extrazellulärraums 
ii) Regulation des Blutdrucks 
iii) Kontrolle der Na+-Resorption 
 
In der vorliegenden Arbeit richtet sich das besondere Augenmerk auf die Regulation von 
ENaC durch 
i) purinerge Rezeptoren 
ii) CFTR und Veränderungen in der intrazellulären Cl−-Konzentration 
iii) Protein-Kinase CK2 
 
Durch den Einsatz elektrophysiologischer und molekularbiologischer Methoden wird gezeigt, 
dass sowohl die Stimulation purinerger Rezeptoren als auch die Aktivierung von CFTR und 
anderer Cl−-Kanäle die Hemmung epithelialer Na+-Kanäle bewirkt. Dies führt zu einer 
Verminderung der Na+-Absorption. Weitere Experimente bewiesen, dass es sich hierbei um 
additive Mechanismen handelt. Die Aktivierung purinerger Rezeptoren markiert den 
Anfangspunkt einer Signalkaskade, die über Hydrolyse des Phospholipids PIP2 zur Inhibition 
von ENaC führt. In Coexpressionsexperimenten hat die Stimulation von CFTR-Cl−-Kanälen 
oder anderer Cl−-Kanäle, die nach ihrer Aktivierung die intrazelluläre Cl−-Konzentration 
verändern, ebenfalls die Hemmung des epithelialen Na+-Kanals zur Folge. Es ließ sich ein 
Zusammenhang herstellen zwischen dem Ausmaß der ENaC-Hemmung und dem Anstieg 
der intrazellulären Cl−-Konzentration. Eine ähnliche Korrelation wurde bezüglich der Inhibition 
von ENaC durch Stimulierung purinerger Rezeptoren gefunden. Während die Bindung von 
ENaC an PIP2 den Kanal in einem aktiven Zustand hält, scheint sich das Interferieren von 
ENaC mit intrazellulärem Cl− hemmend auf seine Funktion auszuwirken. 
 
Um CFTR-Studien unter Bedingungen durchführen zu können, die denen im nativen 
Gewebe entsprechen, wurden aus MDCK Typ II-Zellen (polarisierte Hunde-
Nierenepithelzellen) zwei neue Zelllinien geschaffen, die wt-CFTR oder dessen mutiertes 
Gegenstück F508del-CFTR stabil exprimieren. Die Zelllinien wachsen erwiesenermaßen als 
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dichte Ein-Zell-Schichten und eignen sich daher für Ussing Kammer-Experimente. Die 
spätere Coexpression von ENaC wird es erlauben, die Interaktion zwischen CFTR und 
ENaC in einem polarisierten Epithel zu untersuchen. 
 
CK2 ist eine konstitutiv aktive Protein-Kinase, die Einfluss auf die Aktivität des Kanals nimmt, 
indem sie an die β- und γ Untereinheit von ENaC bindet und diese phosphoryliert. Das 
Fehlen dieser Phosphorylierungsstellen oder die Dephosphorylierung einer dieser Stellen 
führt zu einer deutliche Abnahme der Aktivität des epithelialen Na+-Kanals. Diese und andere 
Experimente deuten darauf hin, dass die Phosphorylierung von β- und γENaC durch CK2 die 
Bindung der Ubiquitin-Ligase Nedd4-2 an ENaC verhindert. Die fehlende Bindung von 
Nedd4-2 an ENaC dürfte sowohl zu einer verringerten Endozytose und zur Anhäufung von 
ENaC in der Zellmembran als auch zu einer Zunahme der Aktivität von ENaC führen. 
 
Ein besseres Verständnis der Mechanismen, die an der Regulation des epithelialen Na+-
Kanals beteiligt sind, könnte zur Identifizierung neuer therapeutischer Wege beitragen. Auf 
diese Weise könnten Erkrankungen, die mit einer Fehlfunktion von ENaC in Zusammenhang 
stehen, effektiver behandelt werden, wodurch sich Lebensqualität und Prognose der 
Patienten verbessern könnten. 
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